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Future API Manufacturing Excellence
Abstract

Many pharmaceutical manufacturing processes are costly, time-intensive, and energy-intensive. Due to the
high operational costs, optimization of these processes would result in large economic savings. Fluid bed
granulation takes inputs of air temperature, air flow rate, phase duration, binder spray rate, and inlet air
humidity. A series of simulations were run to determine optimal operating conditions. It was determined that
the process parameters should be limited to the following to meet product standards and reduce costs: air flow
rate of 2800 (m3/h), inlet air temperature of 55˚C for spraying and 75˚C for drying, phase duration 124
minutes , binder spray rate of 900 g/s, and inlet air humidity can range from 1-20 g water/kg air. The
lyophilization simulation takes process inputs of maximum process time, temperature, pressure, and vial type
and returns outputs of peak product temperature, drying time, and maximum sublimation rate. Several
primary drying simulations were run for an 8R vial dose and a 20 mL vial dose to determine the optimal
operating conditions. The conditions that resulted in the greatest operational cost savings for both the 8R vial
and the 20 mL vial were a pressure of 30 Pa, an initial temperature of -9˚C and a final temperature of 1˚C.
Based on the proposed conditions, both operational cost and equipment depreciation savings were identified
mainly due to lower run times across both processes. For fluid bed granulation, $31,136 operational annual
savings were identified amounting to $467,000 over the 15-year project. For lyophilization, $23,500 in annual
operational cost savings amounting to $352,000 over the 15-year project life were found. Further operational
savings only yielded marginal improvements in profitability.
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University of Pennsylvania, School of Engineering and Applied Science
Department of Chemical and Biomolecular Engineering
220 South 33rd Street Philadelphia, PA 19104
April 23, 2019
Dear Dr. Amish Patel and Mr. Bruce Vrana:
Enclosed is a proposal for the optimization of the operating conditions of two pharmaceutical
manufacturing processes: fluid bed granulation and lyophilization. Both of these processes were
simulated using a “black-box” mathematical model run on MATLAB software. Each process took
several different inputs and provided outputs to help determine how to best optimize each process.
The project proposal specified a yearly output of 4,000,000 doses of the fluid bed granulation
product, Botilioxin. For lyophilization, 10,000,000 8R vials and 200,000 20 mL vials of the product,
HAJVANOX, per year are required.
Fluid bed granulation is a process that is used to improve the quality of a powdered drug product.
In this process, a binder is sprayed over the product in order to improve physical properties such as
compressibility and flowability, as well as increase particle size. For the simulation model, the
required inputs were air flow rate, air temperature, air humidity, binder spray rate, and phase
duration. Lyophilization is a freeze-drying process for biologic drugs. This project focuses only on
the primary drying step of lyophilization during which ice is sublimated out of the product vials.
The lyophilization simulation takes inputs of chamber temperature, chamber pressure, vial type,
process time and vial location.
After running numerous simulations, we have determined improved operating conditions for both
processes. We recommend that fluid bed granulation be run at inlet air temperatures of 55˚C for
spraying, 75˚C for drying, an air flow rate of 2800 (m3/hr), an air humidity range of 1-20 (g
water/kg air), a binder spray rate of 900 (g/s), and a process end time of 124 minutes. These
conditions result in annual operational savings of $31,100 for the fluid bed products. For
lyophilization, we recommend that it be run at an initial chamber temperature of -9C with a final
chamber temperature of 1C at a chamber pressure of 30 Pa. This would result in annual
operational cost savings of $23,500 for the lyophilized products. Due mainly to a reduction of
process run times, additional savings were identified for equipment depreciation over the project
lifetime. An NPV sensitivity analysis also indicated that further cost savings would have minimal
positive impact on the recommended cases.
Sincerely,
________________________
Emily Cunningham

______________________
Rachel Wilson

______________________
Marc Geagea
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Section 1: Abstract
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Many pharmaceutical manufacturing processes are costly, time-intensive, and
energy-intensive. Due to the high operational costs, optimization of these processes would
result in large economic savings. Fluid bed granulation takes inputs of air temperature, air
flow rate, phase duration, binder spray rate, and inlet air humidity. A series of simulations
were run to determine optimal operating conditions. It was determined that the process
parameters should be limited to the following to meet product standards and reduce costs:
air flow rate of 2800 (m3/h), inlet air temperature of 55˚C for spraying and 75˚C for drying,
phase duration 124 minutes , binder spray rate of 900 g/s, and inlet air humidity can range
from 1-20

𝑔 𝑤𝑎𝑡𝑒𝑟
𝑘𝑔 𝑎𝑖𝑟

. The lyophilization simulation takes process inputs of maximum process

time, temperature, pressure, and vial type and returns outputs of peak product
temperature, drying time, and maximum sublimation rate. Several primary drying
simulations were run for an 8R vial dose and a 20 mL vial dose to determine the optimal
operating conditions. The conditions that resulted in the greatest operational cost savings
for both the 8R vial and the 20 mL vial were a pressure of 30 Pa, an initial temperature of 9˚C and a final temperature of 1˚C. Based on the proposed conditions, both operational cost
and equipment depreciation savings were identified mainly due to lower run times across
both processes. For fluid bed granulation, $31,136 operational annual savings were
identified amounting to $467,000 over the 15-year project. For lyophilization, $23,500 in
annual operational cost savings amounting to $352,000 over the 15-year project life were
found. Further operational savings only yielded marginal improvements in profitability.
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Section 2: Introduction and
Objective Time Chart
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Section 2.1 Introduction
We are members of a strategy group in a large pharmaceutical company that focuses
on developing business cases for potential high-impact technologies. For our report, we
have been given access to mathematical models that simulate two pharmaceutical
manufacturing processes: fluid bed granulation and lyophilization. We are interested in
using these models to optimize these processes for two different products.
Botilioxin is a small molecule drug manufactured in China and sold in the EU
market. It is a high-volume generic drug that is off-patent, but still a well-recognized brand
name. Botilioxin is a tablet that is taken orally and undergoes the process of fluid bed
granulation during manufacturing.
HAJVANOX is a new large molecule drug that is manufactured in Switzerland and
mainly sold to the EU market. HAJVANOX is currently patented and by nature of being a
biologic, it is unlikely to experience significant competition even when it goes off-patent. It
is a freeze-dried antibody that is administered to the patient via intravenous injection,
typically in a hospital setting. HAJVANOX is a lower volume product that goes through the
process of lyophilization or freeze drying.
Section 2.1.1 Fluid Bed Granulation
Fluid bed granulation (FBG) is a process in which powder granules are treated with
binders in order to increase the quality of the product downstream. The advantages of this
process are that it creates an environment for high rates of heat and mass transfer, leading
to uniform temperature distribution and shorter processing times (Ennis, Tardos, &
Turton, 1998). This process allows for the product to achieve more desirable properties
11

like improved flowability, appearance, reduction of dust, and compressibility. The main
steps of focus in the fluid bed granulation process are coating and drying.
During the coating process, a liquid binder is pumped into a bed of powdered
product. The product is contained in a mixer, which provides shearing forces within the
powdered mass. While the binder solution evaporates, the particles of product agglomerate
together, forming larger particle sizes. This is caused by the interparticle bridges and
capillary regions strengthening resulting in increased particle size. A gas, typically purified
air, is used to change temperature of the product during different phases. While this type of
granulation possesses many complexities, it provides the ability to both heat and cool the
product at the same time (Ennis et. al., 1998). For this process, all operations occur at
atmospheric pressure.
During the coating step of the operation, the powdered product is sprayed with a
binder solution that allows the particles to agglomerate together and form even larger
particles. When the liquid is sprayed onto the particles, the liquid distributes itself amongst
the powder and creates liquid bridges amongst them. As the process continues, more liquid
bridges are formed between particles which alters the bulk properties of the product. This
action is continued until the desired particle size is reached. To determine this, the critical
binder liquid to powder ratio must be calculated through experimental methods. While the
powder is agitated, the binder is slowly added in order to easily track the differences in
binder concentration (Ennis et. al., 1998). The torque of the pump and the electric power
required are monitored. This produces a plot of torque versus the amount of liquid added
to the powder. Based on this information, the critical ratio can be determined for any
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product. In this project, the assumption has been made that the required ratios for this
product have been accounted for in the simulation.
While the binder is being pumped over the agitated bed, purified air is blown
through the process as well. The purpose of the air is to control the heat and mass transfer
of the process. During this phase, the air temperature is maintained between 46˚C and 55˚C,
which have been determined to be the optimal temperatures for the process. The
temperature of the air is controlled by a countercurrent heat exchanger.
The final step in the fluid bed granulation process is drying. During this step, the air
temperature is increased to a critical temperature that will dry the product to a specified
loss of drying percentage (LOD%). For this application, the optimal air temperature for
drying falls between 70˚C and 75˚C. Loss of drying percentage is defined as the moisture
content that the powder reaches during operation. The values of concern in this application
are the End LOD% and Max LOD% values. End LOD% is the moisture content of the
product at the end of the operation and Max LOD% is the maximum moisture that the
product reaches during operation. It is preferred the product reaches its Max LOD% at the
end of the operation. After the drying step is completed, the product is moved downstream
to the rest of production.
The main objective for fluid bed granulation in this project is to achieve a more
efficient process which lowers utility costs and produces product that falls within quality
standards.
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Section 2.1.2 Lyophilization
Lyophilization is a freeze-drying process in which ice is sublimed out of the product
vial. This process is typically performed on large molecule drugs because traditional
heating methods would likely destroy the physical structure of the protein. These products
are unstable in the frozen or liquid form, thus freeze drying allows easier storage and
transportation while extending shelf life. Solutions for freeze drying contain 80-95% water
with the active pharmaceutical ingredient along with additives such as buffers, bulking
agents, and stabilizers (Ward, 2019). Not only does lyophilization provide advantages in
storage and transportation but it also allows for modification of the formulation after
manufacturing and prior to administration (Varshney, 2016).
Lyophilization consists of three main steps: freezing, primary drying, and secondary
drying. During freezing, the lyophilization chamber is set at a very low temperature,
approximately 10-20˚C below the product’s freezing point, so that ice nucleation and
crystallization of water occur. The solute will concentrate between ice crystals until it
either crystallizes or forms an amorphous glass (Mortier, 2016). Annealing is an optional
step that may be performed after drying to optimize the ice crystal size and increase the
rate of primary drying. During primary drying, the frozen ice in the vial is sublimated by
setting the chamber to a very low pressure while slowly increasing temperature from the
freezing temperature to provide heat for sublimation. Secondary drying is carried out at a
higher temperature so that any leftover water molecules will evaporate. The product
temperature will be approximately the same as the shelf temperature throughout
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secondary drying and pressure is not an important variable. Once the drying chamber is
free of water vapor, the secondary drying step is complete (Bockstal, 2017).
The process of lyophilization, and primary drying in particular, is extremely time
and energy intensive. Lyophilization is typically run at suboptimal conditions because there
is often low active pharmaceutical ingredient (API) availability during early process
development, making it difficult to run sufficient experiments to determine optimal
operating conditions. Primary drying is the longest and often most important phase. Since
optimization of primary drying will result in the greatest decrease in process times, this
project will focus only on the primary drying step.
In primary drying, once the ice is sublimated, the water vapor is then drawn into the
condenser where it is cooled back into ice. It is assumed that pure water is being
sublimated out of the product, although in reality this solution may contain excipients,
solvents, and other fillers. The majority of the vapor will be comprised of water, so the ice
and vapor are assumed to have the properties of pure water. Each product has a specific
collapse temperature above which there is loss of physical structure of the dried product
cake (Ward, 2019). The product within the chamber must never reach this temperature.
Product temperature is a function of heat and mass transfer, both of which depend on the
physical properties of the product, vial volume and design, shelf temperature, chamber
pressure, and condenser and vacuum pump capacity. The vials at the corners and edges of
the oven receive more heat via radiation so these vials often dry faster than the center
vials, making them the limiting factor in energy transfer due to increased risk of cake
collapse. The vials located at the center of the shelves receive less heat and thus take a
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longer time to dry than the corner or edge vials. The process must be run such that all vials
are sufficiently dry, which is determined by center vials, and all vials are below the collapse
temperature, which is determined by corner vials.
There is a black box mathematical model that simulates primary drying. The model
takes inputs of process time, chamber temperature, chamber pressure, vial location, and
vial type. The chamber temperature was varied from -40 ˚C to 10 ˚C and pressure was
varied from 10 Pa to 40 Pa to determine optimal conditions. The vial location options
included center, edge, and corner. The vial types are 8R and 20 mL vials, which are treated
as two separate products. The model provides outputs of drying time, maximum product
temperature, and maximum sublimation rate.
The goal of this project is to decrease drying time as much as possible while
producing the maximum number of vials at the lowest possible utility usage.
Section 2.1.3 Economic Analysis
The main deliverable of this report details the cost savings from our proposed
operating conditions against the base cases provided. In order to determine cost savings,
operational cost models were constructed that converted operating conditions and process
run times into annual costs for both FBG and lyophilization. Section 20 deals extensively
with how these models were developed and used to provide recommendations.
Additionally, to complete the profitability analysis, a comparison of depreciation schedules
between the base case and proposed conditions is presented in order to see how reduced
run times could lead to savings in equipment depreciation. Several assumptions were made
throughout the development of the cost models which are all detailed later on this report.
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Section 2.2 Project Charter
Name of Project: Future API Manufacturing Excellence
Project Author: Dr. Alex Marchut
Project Advisors: Dr. Amish Patel and Professor Bruce Vrana
Project Leaders: Emily Cunningham, Marc Geagea, and Rachel Wilson
Specific Goals:



Design a faster and/or cheaper lyophilization primary drying process that
satisfies all constraints for a new large molecule product, HAJVANOX
Optimize the granulation of a small molecule high-volume product,
Botilioxin, by finding a global optimum in operation cost

Lyophilization Project Scope:
In Scope







Produce 10,000,000 8R vials and 200,000 20 mL vials per year of product
Satisfy product quality requirements including maximum product
temperature
Satisfy equipment capability constraints including minimum chamber
pressure
Size and cost a vacuum pump
Calculate annual operational cost of base case and new case for both 8R and
20 mL vial products
Determine depreciation savings and global optimum for profitability

Out of Scope







Freezing and secondary drying steps of lyophilization
Raw materials costs
Physical properties of products
Sizing and costing equipment including a condenser, refrigeration system,
and electric heater
Scheduling production, cleaning, and changeover or calculating associated
costs
Market and competitive analysis
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Deliverables:



Operational conditions that show significant savings compared to the base
case
Analysis of how different parameters such as chamber temperature, chamber
pressure, and process time affect operational costs

Fluid Bed Granulation Project Scope:
In Scope






Producing 250 batches per year of product
Satisfy moisture and quality requirements of the product
Maximize equipment capability
Calculate annual operational cost and savings for base case and
recommended case
Determine depreciation savings and global optimum for profitability

Out of Scope







Downstream manufacturing processes
Raw material costs
Sizing and costing a heater, fan, and filters
Physical properties of product
Scheduling production, cleaning, and changeover or calculating associated
costs
Market and competitive analysis

Deliverables



Operational conditions that show significant savings compared to the base
case
Determining if increased efficiency of the process can be achieved

Timeline:





January-February: Perform background research on both processes, form
initial parameter boundaries
February-March: Finalize candidate test range, size and cost additional
equipment, finish developing operational cost function for both processes
March-April: Calculate cost output for all test candidates, finalize
recommendations
April: Write final report with findings
18

Section 3: Innovation Map
N/A
This project does not involve any new material, process/manufacturing, or product
technologies. This project rather involves the investigation of optimal process conditions
for two pre-existing processes. There are no other changes being made to the pre-existing
processes. Therefore, the innovation map section has been omitted from this report.
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Section 4: Market and
Competitive Analysis
N/A
The identities of the products being manufactured are unknown and all market information
is proprietary. Therefore, the market and competitive analysis section has been omitted
from this report.
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Section 5: Customer
Requirements
N/A
Customer requirements were found not to be applicable to this project. The market and
product are not known, and therefore this section has been omitted from this report.
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Section 6: Critical-to-Quality
Variables
N/A
As stated in the previous section, the market for the products produced in this project and
customer requirements are not known. Therefore, Critical-to-Quality Variables cannot be
determined for this project. This section has been omitted from this report.
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Section 7: Product Concept
N/A
No information was provided on the products manufactured using fluid bed granulation or
lyophilization other than the names and the type of molecule. It was found that the focus of
this project was not on the products being produced, but rather the operations and
equipment needed to create the product. Therefore, the Product Concepts section has been
omitted from this report.
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Section 8: Superior Product
Concept
N/A
As stated in the previous section, no products were created or manufactured during this
project. Therefore, the superior product concepts section has been omitted from this
report.
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Section 9: Competitive
Patent Analysis
N/A
There are no patents known of for any products being produced in fluid bed granulation or
lyophilization. It was found that this information was not important in the application of
this project. Therefore, the Competitive Patent Analysis section has been omitted from this
report.
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Section 10: Preliminary
Process Synthesis
N/A
There are no alternative processes being considered for neither fluid bed granulation nor
lyophilization. No new processes are being made so there are no process flowsheets or
synthesis trees. Therefore, the preliminary process synthesis section has been omitted
from this report.
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Section 11: Assembly of
Database
N/A
There are no chemical reactions being studied in this report. The properties of any raw
materials being used are outside of the scope of this project. Therefore, the assembly of
database section has been omitted from this report.
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Section 12: Process Flow
Diagrams and Material
Balances
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Figure 12.1. Required inputs and outputs for the fluid bed granulation simulation. The simulation box
signifies the MATLAB “black box” model that was used throughout this project.
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Figure 12.2. Process flowsheet for the fluid bed granulation process. More information regarding the process
is available in Section 13.
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Figure 12.3. Required inputs and outputs for the lyophilization simulation. The simulation box signifies the
MATLAB “black box” model that was used throughout this project.

31

Figure 12.4. Process flowsheet for the lyophilization process. More information regarding the process is
available in Section 13.
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Section 13: Process
Description

33

Section 13.1 Fluid Bed Granulation Simulation Description

Figure 13.1.1. Piecewise representation showing how the FBG MATLAB model takes inputs in and gives
outputs. This figure was provided via the original project statement.

For fluid bed granulation, a “black-box” simulation model, run through MATLAB,
was provided by the author. This simulation requires six inputs and produces two outputs.
The six inputs are inlet air temperature for the spray step, inlet air temperature for the
drying step, inlet air humidity, inlet air flow rate, spray rate, and phase duration. The two
outputs given were Max Loss of Drying percentage and End Loss of Drying percentage. The
inputs were entered into a matrix, and then run through the MATLAB simulation. Table
13.1.1 describes the significance of each input and output more in detail.
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Table 13.1.1 This table gives a brief description of the process parameters that were chosen for the
simulation. The goal of this project was to narrow down which range of values for each input improved the
process.

Input

Description

Inlet Air Flow Rate

Flow Rate of the air throughout the process

Inlet Air Spray Temperature

Temperature of the air coming out of the HX-01 and into the bed
during the spraying step

Humidity

Humidity of the ambient air coming into the process

Inlet Air Drying Temperature

Temperature of the air coming out of the HX-01 and into the bed
during the drying step

Phase Duration

Time duration of both the spraying and the drying steps in the
process

Binder Spray Rate

Spray rate of the binder being pumped out of P-01

Section 13.2 Fluid Bed Granulation Equipment Flowsheet Description
The process begins with ambient air being purified through filters (FL-01) before
entering the manufacturing space. This filter is located at the inlet of the process. Once the
air is filtered of bacteria and particulate matter, it flows through a condenser (CD-01)
which is responsible for controlling the humidity of the air. The condenser runs 10˚C
cooling water through a coil. Once the air reaches the appropriate humidity value, it is
heated up using a countercurrent heat exchanger (HX-01). Steam is used to heat up the air
to the required temperatures needed for the process. This steam is derived from the
cooling water provided to the plant by heating it up using a traditional electric heater (H01).
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During the spraying process, the inlet air temperature to the bed is 55˚C. This is held
for the duration of the spraying process. For the drying portion, the air temperature is
increased to 75˚C and held constant. The simulation provided does not account for the
process having to achieve equilibrium or any controls. The time to reach equilibrium was
estimated and incorporated into the utility and power requirements of the process. Since
the T between the spraying and drying steps temperatures is 20˚C, an appropriate
equilibration time was determined to be about 5 minutes.
During the spraying process, the binder is pumped through a peristaltic pump (P01) to the bed (UNIT-01). The bed is lined with spray nozzles that evenly distribute the
binder over the product. The binder is continuously sprayed for the duration of this part of
the process. Based on the results compiled by the simulation, the optimal phase duration
for the spraying section is 100 minutes. Air is being blown over the product during this
step as well to encourage an even distribution of binder on the product.
Once all of the binder has been sprayed on the product, drying occurs. During this
step, air at 75˚C is continuously flowed over the product to dry the agglomerated particles.
This phase duration was determined to be optimal in the range of 124-134 minutes. After
all the product is dry, it is stored and transported to the next step in the manufacturing
process. Any air leaving the processes passes through a particulate filter (FL-02) before
reentering the environment.
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Section 13.3 Fluid Bed Granulation Optimization Approach
The goal of this project was to optimize the process while producing product which
fell within quality and product constraints. The only product constraints were the following
mentioned in Table 13.3.1.
Table 13.3.1. This table displays the product constraints recommended by the project author. These values
were the outputs given for each simulation run through the MATLAB model. Loss of Drying signifies the
moisture content that the product achieves during and at the end of the process.

Loss of Drying (LOD)

Percentage (%)

Maximum

4.0-11.4

End

2.0-3.5

For each of the simulations, the outputs would be the Maximum LOD%, End LOD%,
and the phase duration of the spraying and drying steps. If the outputs did not fall within
the ranges provided above, the inputs were determined to be unviable.
In order to narrow down the inputs to the optimal values, an abbreviation of the
full-factorial method was used. This method is traditionally used in statistics when an
experiment has two or more factors, each with discrete values. Instead of performing a full
factorial on six possible inputs for the simulation, the two factors used for the
“abbreviated” method were temperature and air flow rate. It was decided to use these two
inputs because both had wider ranges of values to simulate. Figure 13.3.1 shows a visual of
this abbreviated method.
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(55˚C, 1000g/s)

(55˚C, 800 g/s)

(46˚C, 1000g/s)

(46˚C, 800 g/s)

Figure 13.3.1. This figure gives a visual depiction of the abbreviate full factorial method used to narrow down
the ranges of inputs to start with. The temperature values only correspond to the inlet temperature for the
spraying step. The drying temperature was not taken into consideration.
(https://www.itl.nist.gov/div898/handbook/pri/section3/pri3332.htm)

The high inlet temperature is defined as 55˚C air during the spraying step. The low
inlet temperature is defined as 46˚C for the inlet air during the spraying step. The high
binder spray rate is defined as 900 (g/s) and low spray rate is defined as 750 (g/s). A series
of simulations were run at each of the four corners while the other inputs values were held
constant. It was found that the simulations that produced outputs falling closest to the
product LOD% constraints were those that operated at smaller T values between
spraying and drying temperatures and high binder spray rates. It was decided to focus on
this range of values as a starting point in order to optimize all other values in the process.
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The other simulations produced product that was too dry, low LOD%, and could not be
viable. The results of all the preliminary simulations are in the Appendix.
Once it was determined that successful simulations had high inlet air temperatures
during the spraying step and high binder spray, other parameters were optimized. The next
parameter tested was the phase duration of the drying time. The base case runs at a drying
time of 175 minutes. With this process time, it was found that the product was still too dry
after the operation was finished.
In order to increase the moisture of the product, a series of simulations were run at
lower drying times. The constraints on the drying time provided by the project instructions
were 100-200 minutes. It was determined that the optimal drying times were between
120-134 minutes. The results of the simulations altering the drying phase times are located
in Appendix A.
The binder spray rate was determined to be optimal at 900 g/s. This value was
found to achieve the correct LOD% values needed for product quality.
The inlet air humidity is a parameter that must be held constant at 7.6 g water/kg
air. This value was used in all of the simulations that were ran for this project. There were
some experiments using lower values of humidity, ranging from 3-6.2 g water/kg air. These
tests were done because of how the condenser works in the real application of this project.
Based on what was provided by the project author, the condenser operates with no
humidity controls. This means that no matter what the ambient air humidity is, the air will
still enter the process.
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In order to ensure that the product would fall within LOD% constraints with any
humidity air value, which in this climate can range from 3-20 g water/kg air, the other
process parameters were optimized. A series of simulations were run at different humidity
values, available in Appendix A. It was found that the humidity value did not have a
significant effect on the final LOD% values of the product. Therefore, it was determined
that the humidity should be held at a constant value for the process. As shown in the utility
requirements section, the value is held constant at 7.6 g water/kg air.
Section 13.4 Lyophilization Simulation Description

Figure 13.4.1. Piecewise representation showing how the lyophilization MATLAB model takes inputs in and
gives outputs. This figure was provided via the original project statement.
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The simulation is run with MATLAB or MATLAB Runtime and requires three inputs
in the form of a 3 x 3 matrix. The first column of the matrix is process time in hours, the
second column is shelf temperature (˚C), and the third column is chamber pressure (Pa).
Another input is vialGroup, which identifies the location of the group of vials for which the
simulation is occurring. The options are center, corner, and edge. Corner vials receive the
most heat because they are located near the chamber walls and thus receive more heat via
radiation. Center vials receive the least heat because they are furthest from the chamber
walls. The last input is vialType, which specifies whether the vial being used is 8R or 20 mL.
These vials have different geometries and different heat transfer coefficients. The process
must be optimized individually for 8R and 20 mL vials, since these are essentially two
different products.
The simulation has three outputs: drying time (h), peak product temperature (˚C),
and maximum sublimation rate (g/s). The drying time is the amount of time necessary to
sublimate at least 99.9% of the ice out of the vial. In order for a lyophilization run to be
successful, every vial type (center, edge, and corner) must be dried to completion. It is
expected that center vials will have the longest drying time since they are receiving the
least heat, so the drying time of the center vials is used as the overall drying time for the
process. There is no danger of excessive drying, so it alright if the corner and edge vials are
dried before the center vials as long as they don’t exceed the collapse temperature.
The peak product temperature is the maximum temperature that the product
reaches during drying. This temperature must be below the collapse temperature, which is
estimated to be approximately -20 ˚C. Because the corner vials are receiving the most heat
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and thus will have the highest peak product temperature, the peak product temperature of
the corner vials is used as a process constraint.
The peak sublimation rate (PSR) of the vial, which is given in g/s, is the highest
sublimation rate for any single vial during the run. The condenser can only remove a
limited amount of water at a given time which creates a constraint for the peak sublimation
rate. There is a given equation relating the minimum allowable chamber pressure, Pmin, to
the total peak sublimation rate, PSRtot, which is the value obtained assuming all vials are
operating at the peak sublimation rate. Because the corner vials are expected to receive the
most heat when compared to edge or center vials, the PSR of the corner vials is used to
determine Pmin.
For N vials where N is between 10,000 and 60,000 vials:
𝑃𝑆𝑅𝑡𝑜𝑡 (

𝑘𝑔
𝑘𝑔
𝑠
) = 𝑁 ∗ 𝑃𝑆𝑅 ∗ 0.001
∗ 3600
ℎ𝑟
𝑔
ℎ𝑟

Given this value of PSRtot, Pmin can be calculated using the following equation:
2
𝑃𝑚𝑖𝑛 (𝑚𝑡𝑜𝑟𝑟) = 𝑎 + 𝑏 ∗ 𝑃𝑆𝑅𝑡𝑜𝑡 + 𝑐 ∗ 𝑃𝑆𝑅𝑡𝑜𝑡

𝑎 = 6.0071 𝑚𝑇𝑜𝑟𝑟
𝑏 = 1.1752

𝑚𝑇𝑜𝑟𝑟 ∗ ℎ𝑟
𝑘𝑔

𝑐 = 0.2131 𝑚𝑇𝑜𝑟𝑟 ∗

ℎ𝑟 2
𝑘𝑔2

The value of Pmin must be such that the pressure at which the chamber is operating, Pchamber,
is greater than Pmin
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𝑃𝑚𝑖𝑛 < 𝑃𝑐ℎ𝑎𝑚𝑏𝑒𝑟
This equation is used to determine the maximum value of N, the number of vials, that the
chamber can accommodate at the given process temperature and pressure. To be safe, we
will require that Pmin be at least 1 Pa lower than the chamber pressure.
Section 13.5 Lyophilization Equipment Flowsheet Description
The product is contained in glass vials, 8R or 20 mL, which are loaded into the
lyophilization chamber (UNIT-01). The chamber contains ten stainless steel shelves, each
of which holds 1,000 to 6,000 vials for a total of 10,000 to 60,000 vials per batch depending
on the selected batch size (GEA Group). The shelves are hollow and contain circulating
silicon oil (SIO-01) that is used to change the temperature of the shelves and thus the vials
(Low Temperature Silicon). The silicon oil runs through tubes that are connected to a
circulating pump, an electric heater (H-01), and a refrigeration unit (R-01). During freezing,
the silicon oil is cooled by the refrigeration unit. During primary and secondary drying, the
silicon oil is heated by the electric heater. The lyophilization chamber is connected to a
separate condenser chamber (CD-01) that is maintained at a significantly lower
temperature. When the ice in the product vials sublimates, the vapor will preferentially
move towards the condenser (Nireesha, 2013). In the condenser chamber, the vapor will
immediately undergo deposition upon contact with the cooling coil. The cooling coil is
hollow stainless steel that has cold silicon oil (SIO-02) running through it which is cooled
by the refrigeration system. A vacuum pump (P-01) is attached to the condenser chamber
that is responsible for decreasing the pressure of the lyophilization chamber from
atmospheric pressure to the low pressures required for primary and secondary drying.
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Section 13.6 Lyophilization Optimization Approach
In order to narrow down the number of simulations that needed to be run, we took
a modified factorial design of experiment approach. From literature, it was determined that
the minimum operating pressure for this process is approximately 10 Pa and the maximum
operating pressure is approximately 40 Pa (Ward, 2019). The minimum starting
temperature that was considered was -30˚C and the maximum starting temperature that
was considered was -5˚C.
The first step of this project was determining a design space that includes all of the
temperature and pressure combinations that satisfy both product constraints and
equipment constraints (Office of Regulatory Affairs). Several preliminary simulations were
run to identify four corners of the design space: high temperature and high pressure, high
temperature and low pressure, low temperature and high pressure, and low temperature
and low pressure (Bockstal, 2017).
The design space for the 8R vial product was determined as follows: the high
temperature and high pressure corner was identified at -9˚C and 40 Pa at which point the
peak product temperature exceeded product quality constraints. The high temperature and
low pressure corner was identified at -5˚C and 10 Pa at which point the equipment
constraints allow only 30,000 vials per batch, making these conditions economically
unfavorable. The low temperature and high pressure corner was identified at -28˚C and 40
Pa at which point the drying time was 40 hours, which significantly exceeds the drying time
of the base case. The low temperature and low pressure corner was identified at -28˚C and
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10 Pa at which point the drying time was 40 hours, which also significantly exceeds the
drying time of the base case.

Figure 13.6.1. This figure gives a visual depiction of the abbreviated full factorial method used to narrow
down the ranges of inputs to start with for the 8R vial design space.

The design space for the 20 mL vial product was determined as follows. The high
temperature and high pressure corner was identified at 5˚C and 40 Pa at which point the
peak product temperature exceeded the product quality constraints. The high temperature
and low pressure corner was identified at -15˚C and 10 Pa at which point the equipment
constraints allow only 10,000 vials per batch, making these conditions economically
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unfavorable. The low temperature and high pressure corner was identified at -28˚C and 40
Pa at which point the drying time was 35 hours, which significantly exceeds the drying time
of the base case. The low temperature and low pressure corner was identified at -33˚C and
10 Pa at which point the drying time was 30 hours, which is significantly higher than the
base case and all other 20 mL vial simulations performed.

Figure 13.6.2. This figure gives a visual depiction of the abbreviated full factorial method used to narrow
down the ranges of inputs to start with for the 20 mL vial design space.
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Once the design space was determined, every point within the design space ranging
from -28˚C to -5˚C was tested at pressures of 10 Pa, 20 Pa, 30 Pa, and 40 Pa. The results are
included in the appendix. The utility and labor requirements were calculated for each
simulation based on the temperature and pressure conditions as well as process time. The
total operational cost was determined for each point and the simulation with the lowest
operational cost was used as the new case. For the 8R vial, this was the simulation
occurring at a pressure of 30 Pa with T1=-9˚C and T2=1˚C.
An additional constraint is the fact that both processes must use the same
equipment. The electric heater, refrigeration system and condenser are all sized based on
other processes within lyophilization and thus it is assumed that both vials use these same
pre-existing pieces of equipment. The vacuum pump, however, will be sized depending on
the most efficient operating pressure. This pressure will be determined based on operating
conditions for the 8R vials rather than the 20 mL vials. 8R vials are a much higher volume
product and thus the optimization of the 8R process will result in the greatest cost savings.
The 20 mL vial operating conditions thus must use the pressure that is predetermined by
the 8R vial optimum operating conditions. The operating pressure must therefore be 30 Pa.
For the 20 mL vial, the most efficient operating conditions at 30 Pa occur at temperatures
of T1=-9˚C and T2=1˚C.
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Section 14: Energy Balance
and Utility Requirements
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Section 14.1 Fluid Bed Granulation
Energy balances are not applicable to this project. The major utility requirements
for this process are electricity, cooling water, and steam. Because the product is being made
in a pre-existing plant, utility supply systems are out of the scope of this project. Only utility
requirements for operation will be discussed. All intrinsic variables were determined using
Engineering Toolbox. The utility requirements are based on the aforementioned
recommended operating conditions for this process. These recommendations are listed in
Section 23 of this report.
Table 14.1.1. Fluid Bed Granulation Base Case Utility Requirements per Batch

Equipment

Electricity
Requirement (kw)

Steam Requirement
(kg/s)

HX-01
CD-01

Cooling Water (kg/s)

.584
1.073

P-01

.012

H-01

1439

F-01

7.06

Total

1447.145

0.128

.584

1.168

0.128
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Table 14.1.2. Fluid Bed Granulation Recommended Case Utility Requirements per Batch

Equipment

Electricity
Requirement (kw)

HX-01

Steam Requirement
(kg/s)

Cooling Water (kg/s)

.636

CD-01

1.11

P-01

.013

H-01

1568

F-01

7.31

Total

1576.433

0.132

.636

1.272

0.132

As displayed in the tables above, the utility requirements for each piece of
equipment increased from the base case. This stems from the reduction in process time.
Though the requirements increase, the time duration for the process decreases resulting in
cost savings. More information regarding cost savings is presented in Sections 20 and 21.
Section 14.2 Lyophilization
Energy balances are not applicable to this project. The major utility requirements
for this process are electricity and cooling water. Because the product is being made in a
pre-existing plant, utility supply systems are out of the scope of this project. Only utility
requirements for operation will be discussed. The utilities for each product’s base case
operational conditions and new case operational conditions are shown below. For the 8R
vial product, the new case requires 24.06 kW electricity more than the base case and 42
gallons cooling water more than the base case. For the 20 mL vial product, the new case
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requires 9.75 kW electricity more than the base case and 10,909 gallons of water less than
the base case.
Table 14.2.1. 8R Base Case Utility Requirements per Run

Electricity (kW)

Electric Heater

28.56

Condenser

21.79

Vacuum Pump

5.09

Total

55.44

Cooling Water (gal)

30,916

30,916
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Table 14.2.2. 8R New Case Utility Requirements per Run

Electricity (kW)

Electric Heater

41.50

Condenser

33.12

Vacuum Pump

4.88

Total

79.50

Cooling Water (gal)

30,958

30,958

Table 14.2.3. 20 mL Base Case Utility Requirements per Run

Electricity (kW)

Electric Heater

24.83

Condenser

16.72

Vacuum Pump

5.09

Total

46.64

Cooling Water (gal)

20,618

20,618
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Table 14.2.4. 20 mL New Case Utility Requirements per Run

Electricity (kW)

Electric Heater

40.45

Condenser

11.06

Vacuum Pump

4.88

Total

56.39

Cooling Water (gal)

9,709

9,709
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Section 15: Equipment List
and Unit Descriptions
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Section 15.1 Fluid Bed Granulation Equipment
The equipment required to run fluid bed granulation includes: a condenser, heat
exchanger, pump, heater, fan, and filters. It is assumed the the fluid bed granulator itself
does not require any power. The power utilities of the individual pieces of equipment were
determined to equate the total power required for the overall process. Each piece of
equipment is manufactured of stainless steel to reduce contamination risks. More
information regarding the operation of the equipment can be found in Section 13.
Specification sheets for each piece of equipment can be found in Section 16. Specification
data can be found in Section 17.
Condenser
Unit Name: CD-01
Type: Cooling Coil Condenser
Pressure: 1 atm
Power: 2.22 kW
Material: Stainless Steel
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1
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The condenser is used to control the humidity of the ambient air used in the
process. As described in the process design, ambient air is filtered and run through the
process to dry the product. Based on information provided by the project author, the
condenser operates at a dew point of 7.6 g water/kg of air.
Heat Exchanger
Unit Name: HX-01
Type: Counter-Current Heat Exchanger
Pressure: 1 atm
Power: 35.1 kW
Material: Stainless Steel
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1

The heat exchanger is responsible for heating the air required for the process. After
the air is condensed to meet the desired humidity level, it is then heated back up to the set
point for the inlet air temperature into the bed. The air is on the shell side of the heat
exchanger while steam is flown through the tube side. Steam is used to heat the air rather
than water because water is not able to achieve the required temperature increase. Water
can only be heated up to a maximum of 120˚F (~49˚C) due to the possibility of calcium
deposition on the inside of the tubes.
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The heat exchanger was sized based on the temperature requirements for the
drying portion of the process. Through simulations, it was shown that an inlet air
temperature of 75˚C during the drying step is the most efficient option because it reduces
the drying time of the product.
Steam Heater
Unit Name: H-01
Temperature Change: 130˚C
Pressure: 1 atm
Heat Duty: 44.4 kJ/mol
Power: 1154 kW
Material: Stainless Steel
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1

A heater is required for this process to make steam. The plant provides water at
10˚C. To heat up the steam to the required temperatures, it was determined that a total Q of
44.4 kJ/mol of heat was required. The maximum power that is needed to heat the water to
steam is 1145 kW. More information regarding utility requirements can be found in Section
16.
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Pump
Unit Name: P-01
Type: Peristaltic Pump
Pressure: 1 atm
Material: Silicone Tubing
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1

The pump for this process is responsible for pumping the binder into the bed. Due
to the low binder flow rates, a peristaltic pump is required. These pumps are best for
solutions that are pumped at low flow rates and do not have high possibility of shearing. A
pump was not able to be sized based on the provided literature, so a vendor was contacted.
It was determined that the best pump for this operation is a pharmaceutical pump,
Verderflex Vantage 3000 P EZ Model. This pump’s specifications fall within what is
required for this process. Its maximum flow rate is 1.7 L/min. The pressure the pump
operates at is assumed to be atmospheric (Verderflex).
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Fan
Unit Name: FN-01
Type: Centrifugal Backward Curved Fan
Power: 25.5 kW
Material: Stainless Steel
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1

A fan is used to draw the air through all the required equipment and the bed. The
fan sits at the end of the process, outside of the bed. It has the power to draw in ambient air
through the filter and into the process. Based on literature, a centrifugal backward-curved
fan was determined to be the best option. The specifications of these types of fans fall
within the range of flow rates that is required of the process (Seider et. al., 2010) The
optimal flow rate for the process is 2800

𝑚3
ℎ

. This flow rate accounts for the pressure drops

that are experienced when the air flows through the ambient air filter located at the start of
the process.
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Air Filter
Unit Name: FL-01
Pressure: 1 atm
Material: HV HEPA Filter
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1

The purpose of this filter is to purify the ambient air that enters the process. In
order to remove bacteria and particulate matter, the required mesh size is 0.22-0.44
microns.
Product Filter
Unit Name: FL-02
Pressure: 1 atm
Material: HV HEPA Filter
Specification Sheet: Section 16.1
Design Calculation: Section 26.3.1
Costing Data: Section 17.1
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The purpose of this filter is to prevent product from leaving the fluid bed during
operation. While the air is being blown over the product, the filter acts as a barrier between
the bed and the outside environment. The recommended pore size of this filter is 2-7
microns.
Section 15.2 Lyophilization Equipment
The lyophilization process requires the following equipment: the lyophilization
machine and control panel, a circulating pump, an electric heater, a refrigeration system, a
condenser, and a vacuum pump. The operational costs of the electric heater, refrigeration
system and vacuum pump will be taken into account because these are significant energy
sinks that differ from the base case. The only piece of equipment that will be sized and
costed is the vacuum pump, since this is the only equipment that will change significantly
in price based on primary drying operational conditions. The lyophilization machine,
control panel, and circulating pump will have the same energy usage as the base case and
thus the equipment size and cost will be the same. The sizing of the refrigeration system
and condenser will be determined by the freezing step rather than primary drying, and
therefore the sizing and costing of this equipment is out of the scope of this project.
Similarly, the sizing of the electric heater will be determined by the secondary drying step
rather than primary drying, and therefore the sizing and costing of this equipment is also
out of the scope of this project. All equipment used in the lyophilization process will be
made of stainless steel as is typical of the pharmaceutical industry. More information
regarding the operation of the equipment can be found in Section 13. Specification sheets
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for each piece of equipment can be found in Section 16. Costing data can be found in
Section 17.
Lyophilization Machine and Control Panel
The lyophilization machine and control panel are used to program the process
conditions for lyophilization. They are assumed to use negligible energy in comparison to
the rest of the equipment. The operational costs, sizing and costing of this equipment are
therefore out of the scope of this project.
Circulating Pump
The circulating pump is used to continuously pump silicon oil through the chamber
shelves. The silicon oil is connected to a refrigeration system, an electric heater, and the
chamber shelves. Because the same flow rate of fluid is used in the base case as well as the
new case, the circulating pump will present no differences in operational cost or equipment
cost and therefore these calculations are out of the scope of this project.
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Electric Heater
Base Case 8R Vial Heater

Unit ID: H-01
Type: Electric Heater
Temperature Change: 35˚C
Pressure: 1 atm
Heat Duty: 1.62*106 kJ
Power: 28.6 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3

63

Base Case 20 mL Vial Heater

Unit ID: H-01
Temperature Change: 35˚C
Pressure: 1 atm
Heat Duty: 1.10*106 kJ
Power: 24.8 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3

New Case 8R Vial Heater

Unit ID: H-01
Temperature Change: 46˚C
Pressure: 1 atm
Heat Duty: 1.63*106 kJ
Power: 41.4 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
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New Case 20 mL Vial Heater

Unit ID: H-01
Temperature Change: 46˚C
Pressure: 1 atm
Heat Duty: 1.38*106 kJ
Power: 40.4 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
Costing Data: N/A

The electric heater is used to heat the silicon oil that flows through the chamber
shelves. The heater is used during primary and secondary drying to increase the product
temperature, sublimate ice during primary drying, and evaporate any residual water
during secondary drying. As was previously mentioned, the operational costs of the electric
heater will be calculated but the sizing and costing are out of the scope of this project. An
electric heater was chosen rather than a heat exchanger due its high efficiency and ability
to provide heat slowly to low-temperature heat transfer fluids.
During primary drying, the heater will be used to increase the temperature of the
lyophilization chamber from -45˚C to the initial chamber temperature (T1), which will take
approximately 1.5 hours. After 1.5 hours, the heater will be used to increase the
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lyophilization chamber further from T1 to the final chamber temperature (T2) which will
also take 1.5 hours. The chamber will stay at T2 for the remainder of the primary drying
process. The heater must increase the temperature of the stainless steel shelves, the glass
vials, and the product as well as supply enough heat for sublimation to occur. The electric
heater has an efficiency of 90%. The heat duty and power are calculated in the appendix,
section 26.3.
Refrigeration System and Condenser
Base Case 8R Vial Condenser

Unit ID: CD-01
Type: Cooling Coil
Temperature Change: 10˚C
Pressure: 1 atm
Area: 0.553 m2
Heat Duty: 1.58*106 kJ
Power: 21.75 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
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Base Case 20 mL Vial Condenser

Unit ID: CD-01
Type: Cooling Coil
Temperature Change: 10˚C
Pressure: 1 atm
Area: 0.553 m2
Heat Duty: 1.05*106 kJ
Power: 16.75 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
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New Case 8R Vial Condenser

Unit ID: CD-01
Type: Cooling Coil
Temperature Change: 10˚C
Pressure: 1 atm
Area: 0.553 m2
Heat Duty: 1.58*106 kJ
Power: 33.13 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
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New Case 20 mL Vial Condenser

Unit ID: CD-01
Type: Cooling Coil
Temperature Change: 10˚C
Pressure: 1 atm
Area: 0.553 m2
Heat Duty: 5.28*105 kJ
Power: 11.1 kW
Material: Stainless Steel
Specification Sheet: Section 16.2
Design Calculation: Section 26.3

The condenser is used to cool the vapor coming out of the lyophilization chamber. It
is a large cooling coil containing circulating silicon oil that is cooled by the refrigeration
unit. Water vapor will preferentially enter the condenser chamber from the lyophilization
chamber because of the lower temperature. Once the water vapor contacts the surface of
the condenser, it will immediately turn into ice and drop out of the condenser. As
aforementioned, the operational costs of the refrigeration system and condenser will be
calculated but the sizing and costing are out of the scope of this project.
The surface of the condenser must be maintained at -55˚C. The system will be
initially set at -45˚C from the freezing step and the refrigeration system must remove

69

enough heat from the condenser in order to reach -55˚C after 1.5 hours. The refrigeration
system must remove enough heat to decrease the temperature of the stainless steel
condenser to -55˚C, decrease the temperature of the water vapor, and convert the water
vapor to ice. The refrigeration system has an efficiency of 80%. The heat duty and power
requirements are calculated in the Appendix, section 23.6.
Vacuum Pump
Base Case 8R Vacuum Pump

Unit ID: P-01
Type: Screw Compressor
Material: Stainless Steel
Temperature: -55˚C
Pressure Change: 101,299 Pa
Work: 4.24 kW
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
Costing Data: Section 17.2
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Base Case 20 mL Vacuum Pump

Unit ID: P-01
Type: Screw Compressor
Material: Stainless Steel
Temperature: -55˚C
Pressure Change: 101,299 Pa
Work: 4.24 kW
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
Costing Data: Section 17.2
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New Case 8R Vacuum Pump

Unit ID: P-01
Type: Screw Compressor
Material: Stainless Steel
Temperature: -55˚C
Pressure Change: 101,295 Pa
Work: 4.06 kW
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
Costing Data: Section 17.2
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New Case 20 mL Vacuum Pump

Unit ID: P-01
Type: Screw Compressor
Material: Stainless Steel
Temperature: -55˚C
Pressure Change: 101,295 Pa
Work: 4.06 kW
Specification Sheet: Section 16.2
Design Calculation: Section 26.3
Costing Data: Section 17.2

The vacuum pump is used to achieve the extremely low pressures required by
lyophilization. The pressures that were considered in the design space range from 10 Pa to
40 Pa, putting this process in the medium vacuum range. The best suited vacuum pump for
this range of pressures is the screw compressor, which is a dry vacuum pump capable of
reaching pressures as low as 0.1 torr and achieving a volumetric flow rate at suction
conditions between 50-1,400 ft3/min. Dry vacuum pumps are more efficient than other
vacuum pumps, such as steam-jet ejectors or liquid-ring pumps, and they do not require
working fluids that contribute to air pollution (Ryans, 2001).
The size and cost of the vacuum pump will depend significantly on the operational
pressure, and thus the sizing and costing of the vacuum pump is within the scope of this
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project. The screw compressor will run at 6,000 rpm. The work required by the base case
pump is 4.24 kW and the work required by the new case pump is 4.06 kW, which is
calculated in the Appendix, Section 23. The pump efficiency is approximately 70%. The
purchase cost of the base case pump is $71,817 and the purchase cost of the new pump is
$68,789. Since the difference in purchase cost is minimal relative to the total capital
investment ($7.5 MM), the cost will not have a significant effect on the economics.
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Section 16: Specification
Sheets
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Section 16.1 Fluid Bed Granulation Specification Sheets

HX-01 Air Heat Exchanger
Item No. HX-01
Materials

Cold In

Cold Out

Hot In

Hot Out

12

75

110

140

Pressure (atm)

1

1

1

1

Vapor Fraction

1

1

1

1

Mass Flow (kg/s)

.552

.552

.623

.623

Molar Flow (mol/s)

19.1

19.1

34.6

34.6

.552

.552
.623

.623

Temperature (˚C)

Component Mass Flow
Air
Steam

Design Data
Type: Shell-in-Tube,
Head

Countercurrent,

Fixed

Effective Surface Area: .0086 m2
LMTD: 176˚F (80.3˚C)
Heat Transfer 3.71 𝑊
𝑚∗𝐾
Coefficient:
Tube Side Material: Stainless Steel
Shell Side Material: Stainless Steel
No. Tubes/Pass: 1
No. Passes: 1
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CD-01 Air Condenser
Item No. CD-01

Materials

Cold In

Cold Out

Hot In

Hot Out

10

12

32.5*

12

Pressure (atm)

1

1

1

1

Vapor Fraction

1

1

0

0

Mass Flow (kg/s)

1.36

1.36

.552

.552

Molar Flow (mol/s)

75.5

75.5

30.6

30.6

.552

.552
1.36

1.36

Temperature (˚C)

Component Mass Flow (kg/s)
Air
Water

Design Data
Type: Cooling Coil
Effective Surface Area:

.0086 m2

LMTD: 46.3˚F (7.95˚C)
Heat Transfer 207 𝑊
𝑀∗𝐾
Coefficient:
Tube Side Material: Stainless Steel
Shell Side Material: Stainless Steel
No. Tubes/Pass: 1
No. Passes: 1
*maximum air temperature value, assumptions based off of location’s weather
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H-01 Steam Heater
Item No. H-01
Materials

Cold In

Cold Out

12

75

Pressure (atm)

1

1

Vapor Fraction

0

1

Mass Flow (kg/s)

.623

.623

Molar Flow (mol/s)

34.6

34.6

Temperature (˚C)

Component Mass Flow
Steam

.623

Water

.623

Design Data
Type: Heater
Q: 44.4 kJ/mol
Power: 1,145 kW
Material: Stainless Steel
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P-01 Binder Pump
Item No. P-01

Materials

Binder In

Binder Out

25

25

Pressure (atm)

1

1

Vapor Fraction

0

0

900

900

Temperature (˚C)

Mass Flow (g/s)
Component Mass Flow
Binder (g/s)

900

Design Data
Type: Peristaltic Pump
Flow Rate*: 900 g/s
Power: 0.02 kW
Material: Silicone Tubing
*assuming the density of binder is equal to that of water
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FL-01 Ambient Air Filter
Item No. FL-01
Materials
Pressure (atm)

1

Volumetric Air Flow Rate (m3/h)

2800

Component Mass Flow
Air (m3/h)

2800
2800

Design Data
Type: HEPA H13HV 24.24.12 Filter
Pore Size: .22 m
Material: Mini-pleated Wet Laid Microglass
Area: 430 ft2
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FL-02 Product Filter
Item No. FL-02

Materials
Pressure (atm)

1
0

Volumetric Air Flow Rate (m3/hr)

2800

Component Mass Flow
Air (m3/h)

2800
2800

Design Data
Type: HEPA H13HV 24.24.12 Filter
Pore Size: 7 m
Material: Mini-pleated Wet Laid Microglass
Area: 430 ft2
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FN-01 Air Flow Fan
Item No. FN-01

Materials
Pressure (atm)

0.97

Volumetric Flow Rate (m3/h)

2800

Component Mass Flow
Air (kg/h)

3553

Design Data
Type: Centrifugal Backward Curved Fan
Fan Efficiency: 0.6
Power: 25.5 kW
Material: Stainless Steel
Head: 19.31 (in. H2O)
Electric Motor 0.9
Efficiency:
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Section 16.2 Lyophilization Specification Sheets

H-01 Electric Heater (8R Base Case)
Item No. H-01
Materials

Cold In

Cold Out

-45

-10

Pressure (atm)

1

1

Vapor Fraction

0

1

Mass Flow (kg/s)

N/A

N/A

Molar Flow (mol/s)

N/A

N/A

Temperature (˚C)

Design Data
Type: Heater
Q: 1.62*106 kJ
Power: 28.6 kW
Material: Stainless Steel
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H-01 Electric Heater (20 mL Base Case)
Item No. H-01

Materials

Cold In

Cold Out

-45

-10

Pressure (atm)

1

1

Vapor Fraction

0

1

Mass Flow (kg/s)

N/A

N/A

Molar Flow (mol/s)

N/A

N/A

Temperature (˚C)

Design Data
Type: Heater
Q: 1.10*106 kJ
Power: 24.8 kW
Material: Stainless Steel
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H-01 Electric Heater (8R New Case)
Item No. H-01

Materials

Cold In

Cold Out

-45

1

Pressure (atm)

1

1

Vapor Fraction

0

1

Mass Flow (kg/s)

N/A

N/A

Molar Flow (mol/s)

N/A

N/A

Temperature (˚C)

Design Data
Type: Heater
Q: 1.63*106 kJ
Power: 41.4 kW
Material: Stainless Steel
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H-01 Electric Heater (20 mL New Case)
Item No. H-01
Materials

Cold In

Cold Out

-45

1

Pressure (atm)

1

1

Vapor Fraction

0

1

Mass Flow (kg/s)

N/A

N/A

Molar Flow (mol/s)

N/A

N/A

Temperature (˚C)

Design Data
Type: Heater
Q: 1.38*106 kJ
Power: 40.4 kW
Material: Stainless Steel
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CD-01 Vapor Condenser (8R Base Case)
Item No. CD-01
Materials

Cold In

Cold Out

Hot In

Hot Out

-55

-55

-10

-55

Pressure (atm)

1

1

1

1

Vapor Fraction

0

0

1

0

Mass Flow (kg/s)

N/A

N/A

6.05*10-3

6.05*10-3

Molar Flow (mol/s)

N/A

N/A

0.336

0.336

6.05*10-3

6.05*10-3

Temperature (˚C)

Component Mass Flow (kg/s)
Water

Design Data
Type: Cooling Coil
Effective Surface Area:

0.553 m2

Material: Stainless Steel
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CD-01 Vapor Condenser (20 mL Base Case)
Item No. CD-01
Materials

Cold In

Cold Out

Hot In

Hot Out

-55

-55

-10

-55

Pressure (atm)

1

1

1

1

Vapor Fraction

0

0

1

0

Mass Flow (kg/s)

N/A

N/A

4.64*10-3

4.64*10-3

Molar Flow (mol/s)

N/A

N/A

0.258

0.258

4.64*10-3

4.64*10-3

Temperature (˚C)

Component Mass Flow (kg/s)
Water

Design Data
Type: Cooling Coil
Effective Surface Area:

0.553 m2

Material: Stainless Steel
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CD-01 Vapor Condenser (8R New Case)
Item No. CD-01
Materials

Cold In

Cold Out

Hot In

Hot Out

-55

-55

1

-55

Pressure (atm)

1

1

1

1

Vapor Fraction

0

0

1

0

Mass Flow (kg/s)

N/A

N/A

9.19*10-3

9.19*10-3

Molar Flow (mol/s)

N/A

N/A

0.510

0.510

9.19*10-3

9.19*10-3

Temperature (˚C)

Component Mass Flow (kg/s)
Water

Design Data
Type: Cooling Coil
Effective Surface Area:

0.553 m2

Material: Stainless Steel
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CD-01 Vapor Condenser (20 mL New Case)
Item No. CD-01
Materials

Cold In

Cold Out

Hot In

Hot Out

-55

-55

1

-55

Pressure (atm)

1

1

1

1

Vapor Fraction

0

0

1

0

Mass Flow (kg/s)

N/A

N/A

3.06*10-3

3.06*10-3

Molar Flow (mol/s)

N/A

N/A

0.170

0.170

6.05*10-3

6.05*10-3

Temperature (˚C)

Component Mass Flow (kg/s)
Water

Design Data
Type: Cooling Coil
Effective Surface Area:

0.553 m2

Tube Side Material: Stainless Steel
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P-01 Vacuum Pump (8R and 20 mL Base Case)
Item No. P-01

Materials

In

Out

-55

20

Pressure (atm)

2.56*10-4

1

Vapor Fraction

1

1

6.25*10-4

6.25*10-4

6.25*10-4

6.25*10-4

Temperature (˚C)

Mass Flow (kg/s)
Component Mass Flow (kg/s)
Air

Design Data
Type: Screw Compressor
Suction at flow: 0.0120 m3/s
Power: 4.24 kW
Material: Stainless Steel
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P-01 Vacuum Pump (8R and 20 mL New Case)
Item No. P-01
Materials

In

Out

-55

20

Pressure (atm)

2.96*10-4

1

Vapor Fraction

1

1

6.25*10-4

6.25*10-4

6.25*10-4

6.25*10-4

Temperature (˚C)

Mass Flow (lb/hr)
Component Mass Flow
Air

Design Data
Type: Screw Compressor
Flow Rate: 0.0103 ft3/min
Power: 4.10 kW
Material: Stainless Steel
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Section 17: Equipment Cost
Summary
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Section 17.1 Fluid Bed Granulation Equipment Cost Summary
No additional pieces of equipment needed to be sized for the fluid bed granulation
portion of this project because no additional pieces of equipment needed to be purchased.
The heater and the filters were not able to be costed. The pump cost was provided by the
vendor. Some preliminary design calculations were made for a few pieces of equipment
based on equations from the Product and Process Design Principles textbook (Seider).
Please make note that due to the constraints of this process, it did not fall within the
guidelines of the costing spreadsheet provided by Dr. Vrana and CBE 459. Because the
costing spreadsheet was not used, the cost of the heat exchanger and condenser may differ
from typical values. Refer for Section 26.3.1 for more information.
Table 17.1.1 Fluid Bed Granulation Equipment Costs

Equipment

Bare Module Cost

Purchase Cost

HX-01

$1,418,753.65

$5,776,320.53

CD-01

$12,006,523.71

$48,004,410.96

F-01

$2,728.80

$9,891.9

P-01

N/A

$300-$500

H-01

N/A

N/A

FL-01

N/A

N/A

FL-02

N/A

N/A
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Section 17.2 Lyophilization Equipment Cost Summary
The only piece of equipment in lyophilization that must be separately sized and
costed is the vacuum pump, which is a screw compressor. Vacuum size is mainly a function
of pressure, and we would expect a vacuum pump that must reach lower pressures to cost
more than a vacuum pump that must reach slightly higher pressures because it will take
more energy to maintain a tighter pressure seal. This expectation is valid as the base case
vacuum pump which operates at 26 Pa costs $284,397 whereas the new case vacuum
pump which operates at 30 Pa costs significantly less at $272,406. The savings in
equipment cost that result from changing operation conditions are $11,991.
Table 17.2.1 Bare Module Cost of Vacuum Pumps

8R Vial

20 mL Vial

Base Case

$284,397

$284,397

New Case

$272,406

$272,406

The purchase cost of the base case pump is $71,817 and the purchase cost of the new case
pump is $68,789. A materials factor cost of 2 was used because the pump is made out of
stainless steel. A bare-module factor of 3.30 was used, as is typical for any type of pump. A
site investment factor of 1.20 was used because the vacuum pump will be located in a site
in Switzerland. The total factor that the purchase cost was multiplied by was 7.92,
accounting for the material, equipment type, and site location. Detailed calculations are
included in the Appendix, section 26.3.
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Section 18: Scheduling
N/A
Production scheduling is out of the scope of this project. Therefore, the scheduling section
has been omitted from this report.
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Section 19: Fixed Capital
Investment Summary
N/A
There was determined to be no significant additional fixed capital investment to the base
case. Therefore, this section has been omitted from the report.
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Section 20: Operating Cost

98

Section 20.1 General Methodology
For the purposes of this design project, operating cost was not calculated as a fixed
percentage of total capital investment. Because the main findings and recommendations
derived from the analysis involved varying sensitivities to operational cost under certain
operating conditions, operational cost models for both lyophilization and FBG were
constructed in order to delineate between cost savings for proposed conditions. There
were two main components of the operational cost model for both work streams: labor and
utility costs. Raw material and byproduct costs are not within scope to the proprietary
nature of the processes. Our economic model converts input conditions for the process into
calculated operational cost on a per year basis with fixed batch sizes and yearly product
requirement. The main underlying assumption of our calculation is that our processes only
incurs cost when in use. It is assumed that when our process isn’t in use, the same
equipment could be used to run a different process in the plant. Thus, labor costs, for
example, are calculated as the percentage of an employee's total salaries based on the time
spent operating our processes of focus. Additionally, the only utilities considered for both
processes are electricity and water. The following subsections walk through the cost
breakdowns for the base cases to give an understanding of how operational cost was
calculated.
Section 20.2 Fluid Bed Granulation Methodology
Inputs for the fluid bed granulation economic model include process run time,
ambient air humidity and temperature (seasonal), inlet airflow rate, drying stage inlet air
temperature, and binder spray rate. The model outputs labor cost and utilities costs broken

99

down by electricity and water requirement on an annual basis (based on batch
requirements) as well as cost per kg of product produced. A summary of the the inputs and
cost outputs for the base case can be seen in Figure 20.2.1 below.

Figure 20.2.1. Operational cost summary for the base case during summer months with annual and per dose
costs shown.

Figure 20.2.1 shows the operational cost summary for the base case during an average
summer month in China. Because the inlet air humidity and temperature is dependent on
daily ambient conditions, it will fluctuate throughout the year. However, in order to
compare to the base case, the inlet air humidity was assumed to be a constant of 7.6 g
water/kg air because the condenser operates with no humidity constraints. Refer to
section 13.2 to for a more detailed explanation of why the air humidity was held constant.
Again for the purposes of a comparison to the base case, average temperature for summer
months and winter months were assumed as 23˚C and 5˚C based on historical data
(Weatherspark, 2019). Throughout this subsection, only the summer month conditions will
be of focus. The actual yearly operational cost, which can be seen in section 20.4.1, was
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calculated as the weighted average of the summer and winter months cost. Figure 20.2.2
displays the detailed labor costs for the base case in the summer months.

Figure 20.2.2. Labor cost summary for the base case with calculated costs per run and dose of $35.94 and
$0.002.

In calculating labor costs, some basic assumptions about shift lengths, working days
per month, overtime shifts, and wage benefits were made. For an average operator earning
$1500 per month in China, with a 50% benefits rate, 8 hour shift length, 22 working days
per month, and 1 overtime shift, the actual hourly rate of an operator comes out to
$12.78/hr (Kelly Services, 2017). The lower value relative to US wage rates is consistent
with labor data in China. Further, for any FBG run, it was assumed that two operators spent
60% of the process time actually incurring costs based on recommendations from the
project author. Using these assumptions, the hourly adjusted wage of a plant operator with
overtime and benefits included is applied to the operator time at the process to calculate
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the labor cost per run at $35.94. Figure 20.2.3 shows in similar detail how the utility costs
were determined.

Figure 20.2.3. Utility cost summary for the base case shown with electricity and water costs amounting to
$326.50 and $2.85 per run respectively

The utility costs were calculated based on the power requirements of the fan,
condenser, heater/heat exchanger system, and pump. For an explanation of how the power
requirements were determined, refer to section 13 of this report. Separate spreadsheets
within the same model take the principles laid out in this section and use the process
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inputs to provide the power requirement for each set of operating conditions. The general
approach took the power requirement after an efficiency factor was applied and multiplied
it through the amount of time that the piece of equipment was assumed to be operating. All
of the equipment was assumed to be operating for 105% of the process time to account for
startup times. Using an average industrial rate for electricity prices in China, the total
electricity costs were calculated on a per run basis to be $326.50 (CEIC, 2018). The only
water required for the process is fed into the electric heater for conversion to steam that is
used in the heat exchanger. The water costs are calculated from steam requirement of the
heat exchanger which is supplied by the steam produced from the electric heater. With
water available at 10˚C for this plant, the average industrial price of water is applied to the
total water requirement to determine the costs per run at $2.85 (World Bank, 2017).
Appendix 26.6 deals further with how these power functions and the water requirements
are handled in relation to the economic model. Figure 20.3.1 shows how the
aforementioned labor and utility costs are summed for the 250 annual batch requirements
to output an annual operational cost. Since this particular generic requires a dose of 0.025
kg, the cost per dose is also provided at $0.02.
Section 20.3 Lyophilization Methodology
Inputs for the lyophilization economic model include process run time, operating
pressure, number of vials, power requirements for the electric heater and
condenser/refrigerator system. Because of the complexity required in calculating power
for the heater and refrigeration, the power calculations were done discreetly and externally
to the model for all the possible test cases. The model outputs a total labor and utilities cost
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for 8R and 20 mL vials given known annual batch requirements as well as a cost per vial of
product. Figure 20.3.1 below details the operational cost summary for the base case of this
process.

Figure 20.3.1. Operational cost summary for the base case with cost broken down by source and vial type.

As can be seen from the figure, the total operating cost under these conditions are
$139,440 for 8R vials and $4,183 for 20 mL vials amounting to a total of $143,623 per year.
It’s important to note that the base case operating conditions do not differ for 8R or 20ml
vials whereas our proposed conditions do differ slightly in this aspect. Similarly to FBG, the
labor costs were calculated solely as a function of process time. Figure 20.3.2 shows how
the labor costs were calculated. The big differences worth noting between the FBG and
lyophilization labor costs were the significantly higher operator wages in lyophilization
which is consistent with the current wage disparities between Switzerland and China.
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Figure 20.3.2. Labor cost summary for the base case with calculated costs per run and vial of product of
$328.50 and $0.006.

The same assumptions for the number of working days per month, benefits, overtime
shifts, and shift lengths used in FBG were applied here. It was additionally assumed that
two operators spent 15% of the process run time incurring labor costs. Using the same
cascade of calculations for labor detailed in section 20.2, labor costs per run and per vial of
product were calculated at $328.50 and $0.006 for the base case (Glassdoor, 2019). The
other main component of this model is the utility cost. Utility costs arise from the electricity
usage of the refrigerator/condenser, electric heater, and vacuum pump as well as the water
costs required for running the refrigerator. Figure 20.3.3 contains the detailed utility cost
breakdown for the base case.
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Figure 20.3.3 - Utility cost summary with $279.42 and $228.78 in electricity costs and water costs per run
summing to $508.20 in total utility costs per run.

Like for FBG, the electricity costs are calculated from a combination of the power
requirement of the equipment, process time, and average electricity cost per kWh in
Switzerland (Market Intelligence Group, 2016). For an explanation of how the power
requirement for each piece of equipment was calculated, see equations located in section
13 of this report. Referring back to Figure 20.3.1, the costs across utilities and labor per are
summed and applied to number of required vials per year to obtain an operating cost.
Section 20.4 Main Cost Drivers
A summary of the base case costs can be seen in Table 20.4.1. In order to propose
the conditions with the greatest cost savings, the operational cost of the base case was
compared to the cost for many different conditions. The recommended conditions with the
greatest observed cost savings are dealt with later on in Section 21. However, in finding
these conditions, trends among the main cost drivers in each process are discussed here to
give general recommendations of how to optimize similar processes.
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Table 20.4.1. Summary of the yearly/per product operational costs for the base case across both processes
Case

Process

Base

Lyophilization (8R)

Base

Lyophilization (20ml)

Total

Labor costs
($/year)

Utility costs
($/year)

Operational cost
($/year)

Cost per dose ($)

$54,750.70

$84,689.92

$139,440.62

$0.01

$1,642.52

$2,540.76

$4,183.22

$0.02

Lyophilization

$56,393.22

$87,230.68

$143,623.90

-

Base

FBG (summer)

$13,062.01

$82,336.20

$95,398.21

$0.02

Base

FBG (winter)

$13,062.01

$111,612.00

$124,674.01

$0.03

Total

FBG

$13,062.01

$96,974.10

$110,036.11

-
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Section 20.4.1 Fluid Bed Granulation
The two main cost drivers identified for fluid bed granulation were process time and
inlet airflow rate. A comparison of the cost breakdown for the base and optimal conditions
(see section 21) is presented in Figure 20.4.1.
Base Case Cost Components
Water
1%

Electricity
85%
Labor
Electricity

Optimal Case Cost Components
Water
1%

Labor
14%

Water

Labor
12%

Electricity
87%
Labor
Electricity

Water

Figure 20.4.1. Cost components by percentage of the base and optimal cases

The biggest component of operational cost arises from the electricity usage. After further
investigation within the economic model, the heater and heat exchanger account for more
than 98% of the electricity costs. The power requirement for these two pieces of
equipment is driven by mainly the inlet air flow rate since it is used to calculate the heat
duty required to heat the air to the appropriate drying temperature. Since the power usage
is a function of process time as well, minimizing the inlet airflow rate and process run time
would lead to the greatest operational cost savings.
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Section 20.4.2 Lyophilization
A similar analysis to the one above was performed on the economic model for
lyophilization to determine what was driving the cost.

Base Case Cost Breakdown
Water
27%
Labor
39%

Electricity
34%
Labor
Electricity

Water

Optimal Case Cost
Breakdown
Labor
31%

Water
32%

Labor

Electricity
37%
Electricity

Water

Figure 20.4.2. Cost components by percentage of the base and optimal cases

Figure 20.4.2 details the cost breakdown by component. Unlike in FBG, labor and water
play a much bigger role in the determination of the cost. Since labor is only a function of
process time, it was identified early on as a main driver of the cost for this process. Within
electricity, the electric heater and condenser accounted for around 90% of the costs.
Additionally, water costs arise only from the use of the condenser which is a function of
condenser power and process run time. Since the condenser has a sizeable impact on both
the electricity and water costs, it was prioritized in order to reduce costs. Thus, increasing
shelf temperatures and lowering process run times were the main cost reducers in this
process.

109

Section 21: Profitability
Analysis
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Section 21.1 Analysis of Fluid Bed Granulation Profitability
The profitability of the proposed operating conditions are discussed at length in this
section. First, we consider the observed operational cost savings from the most promising
proposed conditions. Table 21.1.1 below shows the annual and 15-year operational cost
savings against the base of the proposed conditions.
Table 21.1.1. Annual and 15-year operational cost savings from two proposed operating conditions
Process Inlet air Inlet airflow Drying air
Spray
Annual
15-year
time
humidit
rate
temperature
rate
Operationa Operational
Case (min) y (g/kg)
(m^3/h)
(C)
(g/min)
l Cost
Cost

15-year
Savings

Base

200

7.6

2500

72

1200 $110,036.10 $1,650,541.50 -

Popt

124

7.6

2800

75

900

$78,900.12 $1,183,501.80 $467,039.70

P2

124

7.6

2900

75

900

$81,428.67 $1,221,430.05 $429,111.45

For the condition Popt, which prioritizes lowering the process run time at the expense of a
higher inlet airflow rate, the 15-year cost savings amount to $467,039, which is a fair
amount for a generic process that has been in operation already for several years. P2 is
shown to demonstrate the cost saving sensitivity to the inlet airflow rate. Aside from
operational cost savings, we identified further savings in the depreciation of the equipment
due to the reduced process run times. The total capital investment for the process is $7.5
MM. Because our proposed operating conditions do not require equipment that is
significantly more expensive than those of the base case, the capital investment remains at
$7.5 MM.
With an original end time of 200 min per batch, this process accounted for 13.3% of
the total available time of the equipment. Under the 124 min proposed conditions, that
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percentage drops to 8.25%. Thus, the equipment theoretically should depreciate at a lower
rate as a result of the proposed conditions. Table 21.1.2 compares the difference in
depreciation according to the 20-year MACRS schedule (used by parent company of project
author) between the base case and the P1 operating condition.
Table 21.1.2. Comparison of book-value depreciation between the base case and Popt
20-year
MACRS

Year

Book value
(100%)

Base Case
(13.3%)

Popt (8.3%) Savings

Savings/min
reduced

1

3.75%

$281,250.00

$37,416.09

$23,198.03

$14,218.06

$187.08

2

7.22%

$541,500.00

$72,038.45

$44,663.95

$27,374.50

$360.19

3

6.68%

$501,000.00

$66,650.54

$41,323.43

$25,327.10

$333.25

4

6.18%

$463,500.00

$61,661.72

$38,230.36

$23,431.36

$308.31

5

5.71%

$428,250.00

$56,972.24

$35,322.87

$21,649.37

$284.86

6

5.29%

$396,750.00

$52,781.64

$32,724.69

$20,056.94

$263.91

7

4.89%

$366,750.00

$48,790.59

$30,250.24

$18,540.35

$243.95

8

4.52%

$339,000.00

$45,098.87

$27,961.36

$17,137.50

$225.49

9

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

10

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

11

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

12

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

13

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

14

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

15

4.46%

$334,500.00

$44,500.21

$27,590.20

$16,910.01

$222.50

$5,659,500.00 $752,911.58 $466,806.31 $286,105.27

$3,764.54

Totals

75.46%

Over the 15 year period of interest, the savings in book-value of depreciation amount to
$286,105. These savings arise from the reduction of process time as can be seen from the
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savings/minute of process time reduced column. Combining the book-value savings with
the operational cost savings, our proposed condition, Popt, amounts to $753,144 in savings
over the 15-year life of the equipment.
Because of the proprietary nature of this project, no sales or full cost of manufacture
data is available for this product making use of the profitability analysis spreadsheet
impossible. Thus, analyzing the effect of Popt on many of the standard profitability measures
such as ROI and IRR is not within the scope of this report. However, a sensitivity analysis
on the NPV was performed by making assumptions about selling price and cost to
manufacture based on the average selling price of generic small molecules as described by
the equation below.
𝑃𝑟𝑜𝑓𝑖𝑡 𝑀𝑎𝑟𝑔𝑖𝑛 =

𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑠 − 𝐶𝑜𝑠𝑡𝑠
𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑠

Assuming a selling price of $1.00/dose and 90% profit margins based on recommendations
from industrial consultants, Figure 21.1.1 shows the effect on NPV in the over the last 6
years of the project life under 4 cases: base, Popt, 7.5% operational cost savings, and 30%
operational cost savings. Several additional assumptions were made in order to make this
analysis possible - all the capital investment occurred in 2018 (year prior), 15% of the total
depreciable capital was assumed to be working capital, and a 15% discount rate was
applied. The total depreciable capital and resulting depreciation was varied depending on
the usage rate of the process of the FBG equipment. For each case, the annual operational
cost and depreciation were applied to the values of the base case. The effect on NPV at year
15 was observed. For a comprehensive summary of the cash flows, refer to appendix
section 26.7.
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$17,000,000.00

Comparison of NPV over Project Life

$16,500,000.00

Cum. PV (S)

$16,000,000.00
$15,500,000.00
$15,000,000.00
$14,500,000.00
$14,000,000.00
2029
Base

2030
10%

2031
35%

2032
Year

2033

2034

Popt (28.3%)

Figure 21.1.1. NPV comparison over the last 6 years of project life for each operating case.

Only the last 6 years of the project are shown in the figure in order to show areas of
clear deviation from the base case. Popt represents operational cost savings of 28.3% of the
base. Assuming that revenues and non-operational costs remain constant throughout the
15 year life, Popt represents a 1.88% increase in NPV over the base case. The low relative
percentage change is expected due to the savings in operational cost and depreciation only
representing a percentage of the cost. Table 21.1.3 below shows the sensitivity of NPV to
operational cost savings cases.

114

Table 21.1.3. NPV sensitivity to different operational cost savings scenarios

Case

NPV Increase

% NPV Increase

NPV Increase/% cost saved

Base

-

-

-

10%

$ 186,430.73

1.16%

$

18,643.07

Popt (28.3%)

$ 302,970.72

1.88%

$

10,705.68

35%

$ 303,230.31

1.89%

$

10,714.85

As savings theoretically surpass those offered by Popt, there are only marginal gains in NPV
as evidenced by the 0.01% increase in NPV between the 28.3% and 35% case. Thus, further
optimizing past our proposed conditions would not lead to great gains in profitability.
Refer to section 21.2.3 to see notes about the results and shortcomings of this analysis
across both processes.

Section 21.2 Analysis of Lyophilization Profitability
Proposed Operating Conditions
Table 21.2.1. Popt proposed for lyophilization broken down by vial type
Vial

Shelf Temperature Shelf Temperature
Process Run Time
1 (C)
2 (C)
Vials/batch
(hr)

Pressure
(Pa)

8R

-9

1

60000

16.6

30

20ml

-9

1

50000

15.6

30

Table 21.2.1 exhibits the proposed operating conditions for the 8R and 20ml vials.
Although the optimization of these two vial types was approached separately, the optimal
shelf temperatures and pressure were the same. However, the 8R vials should be run at
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60000 vials/batch and for an hour longer than 20ml. A comparison of the annual and 15year cost savings against the base case of Popt is shown in Table 21.2.2.
Table 21.2.2. Annual and 15-year operational costs of the base and recommended cases.
Case
Base
Popt

Annual Operational Cost
$
$

143,623.90
120,042.68

Annual Savings

15-year Operational Cost

15-year Savings

-

$

2,154,358.50

-

$

1,800,640.20

$

$

23,581.22

353,718.30

Popt prioritizes lowering the process run time at the expense of higher power usage by the
condenser and electric heater. The operating pressure is increased from the base case by 4
Pa in an effort reduce the cost associated with the vacuum pump. The increased pressure is
accounted for by the 10˚C higher refrigerator shelf temperatures. The resulting operational
cost savings amount to $23,581 annually and $353,718 over 15 years. The total capital
investment for the process was again $7.5 MM. Our anticipated equipment for the proposed
conditions does not require any non-negligible amount of capital investment. Due to the
lower process time, the equipment will be available for other processes for more time
annually. This lower usage rate results in further savings in depreciation. Table 21.2.3
shows the expected book value of depreciation and resulting savings.
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Table 21.2.3. Comparison of book-value depreciation between the base case and Popt based on different
annual usage rates of the equipment
20-year
MACRS

Year

Book value
(100%)

Base Case
(68.4%)

Popt (45.2%)

Savings

Savings/hr
reduced

1

3.75%

$281,250.00

$192,375.00

$127,125.00

$65,250.00

$7,092.39

2

7.22%

$541,500.00

$370,386.00

$244,758.00

$125,628.00

$13,655.22

3

6.68%

$501,000.00

$342,684.00

$226,452.00

$116,232.00

$12,633.91

4

6.18%

$463,500.00

$317,034.00

$209,502.00

$107,532.00

$11,688.26

5

5.71%

$428,250.00

$292,923.00

$193,569.00

$99,354.00

$10,799.35

6

5.29%

$396,750.00

$271,377.00

$179,331.00

$92,046.00

$10,005.00

7

4.89%

$366,750.00

$250,857.00

$165,771.00

$85,086.00

$9,248.48

8

4.52%

$339,000.00

$231,876.00

$153,228.00

$78,648.00

$8,548.70

9

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

10

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

11

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

12

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

13

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

14

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

15

4.46%

$334,500.00

$228,798.00

$151,194.00

$77,604.00

$8,435.22

Totals

75.46%

$5,659,500.00

$3,871,098.00

$2,558,094.00

$1,313,004.00

$142,717.83

Lyophilization has a much higher usage rate compared to FBG due to the longer process
times. By optimizing around the process time, an additional $1.3 MM in depreciation
savings over the 15-year life of the equipment was identified. In total, $1.67 MM in
operational and depreciation cost savings were identified for our recommendations.
Since the same proprietary measures apply to lyophilization, a similar sensitivity
analysis on the NPV of this project over the 15-year life was performed excluding ROI and
IRR measures. The selling price was assumed to be $10/dose, much higher than for FBG,
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because of this product’s status as a patented biologic, but again is subject to high
variability. A 90% profit margin was again assumed and the total costs were calculated
using the same formula as for FBG. The same methodology for NPV analysis was applied
here as earlier in section 21.1 and the complete cash flows can be found in appendix 26.7.
Four operational cost scenarios were again studied: base case, 7.5% savings, Popt (16.4%
savings), and 30% savings. Figure 21.2.1 shows the NPV over the last 6 years of the project

life in order to differentiate between cases.

Comparison of NPV over Project Life
$40,000,000.00
$39,000,000.00
$38,000,000.00

Cum. PV ($)

$37,000,000.00
$36,000,000.00
$35,000,000.00
$34,000,000.00
$33,000,000.00
$32,000,000.00
$31,000,000.00
$30,000,000.00
2029

2030

2031

2032

2033

2034

Year
Base

30%

7.50%

Popt (16.41%)

Figure 21.2.1 - NPV comparison over the last 6 years of project life for each operating case.

The results of this analysis closely mirror those of FBG. Popt in this case represented 16.4%
of annual operational cost savings. For savings past the recommended conditions, the gain
in NPV is marginal. Table 21.2.4 shows the gains in NPV across the test cases with the
recommended case generating a 5.4% increase in NPV at the end of the project life.
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Table 21.1.3. NPV sensitivity to different operational cost savings scenarios
Case

NPV Increase

% NPV Increase

NPV Increase/% cost saved

Base

-

-

-

7.50%

$

Popt (16.41%)
30%

987,710.90

2.70%

$

131,694.79

$ 1,984,715.11

5.43%

$

120,945.47

$ 2,074,146.15

5.67%

$

69,138.20

The marginal increase in NPV past the recommended conditions are consistent with what
was observed in FBG indicating that further optimization would have little effect on
increasing the NPV of this investment. While the magnitude of the NPV in this process
reaches ~$38 MM, little can be made of it because the dependency on the selling price
assumptions.
Section 21.3 Profitability Caveats
The results of this analysis for both FBG and lyophilization should be weighed
against the validity of the assumptions made. Absolute values of NPV are not accurate of
what the true values are. The relative values and aforementioned trends, however do
provide some insight into how our proposed conditions could affect the NPV of this project.
The effect of the selling price assumption on the NPV was mitigated by keeping the revenue
and non-operational cost values constant. Thus, if selling prices and non-operational cost
assumptions are somewhat within of the actual values, then the trends observed should
hold.
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Section 22: Additional
Considerations
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Section 22.1 Environmental Considerations
Pharmaceutical manufacturing practices tend to use a large amount of utilities
including cold water, steam, and electricity, resulting in very high energy and water usage
demands. Both processes described in this report use a large amount of energy and water,
although lyophilization tends to be more energy-intensive. The objective of this project is
to find optimal operating conditions for both products, which oftentimes translates into
shorter process times and decreased utility usage. Although creating more environmentally
friendly practices was not the main goal of this project, it is a fortuitous result of creating
more economically favorable practices.
The sites of operation described in this paper follow current Good Manufacturing
Practice (cGMP) recommendations for waste disposal, meaning that all waste from both the
fluid bed granulation and lyophilization processes is safely treated within the
manufacturing site before being exposed to the outside environment. Both processes use
the cleaning in place and steaming in place practices that are required by GMP guidelines.
One major environmental and safety concern in fluid bed granulation is dust
production. Dust is problematic because it could either contaminate the production of
other drugs in nearby areas or it could escape into the environment where it would also
have detrimental effects. The fluid bed granulation machine in this process has a dust
sensor on the exhaust pipe. If the sensor detects a minimum mass, then the entire process
will automatically shut down and the operators will determine the cause of the leak. This
sensor ensures that essentially all waste from the fluid bed granulation process is
contained.
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An additional environmental improvement in the lyophilization process is the use of
a dry vacuum pump for the vacuum system rather than a steam-jet ejector or a liquid-ring
pump. Unlike the other two systems, the dry vacuum pump does not use any working fluids
such as steam, water, or oils. The use of these fluids requires extra utilities and also
contributes to air pollution, so the screw compressor is a more environmentally friendly
option.
Section 22.2 Good Manufacturing Practices
Although the fluid bed granulation and lyophilization product are manufactured in
China and Switzerland, respectively, the company is based in the United States and thus the
products follow US requirements. ISPE defines Good Manufacturing Practice (GMP) as “a
system for ensuring that products are consistently produced and controlled according to
quality standards. It is designed to minimize the risks involved in any pharmaceutical
production that cannot be eliminated through testing the final product. GMP covers all
aspects of production from the starting materials, premises, and equipment to the training
and personal hygiene of staff. Detailed, written procedures are essential for each process
that could affect the quality of the finished product. There must be systems to provide
documented proof that correct procedures are consistently followed at each step in the
manufacturing process - every time a product is made (ISPE).”
Both sites have a barcode scanner to scan every excipient that is added to the drug
formulation. If the barcode is incorrect, the entire system will shut down. This ensures that
no incorrect ingredients will ever enter the manufacturing process. The sites are both
capable of handling the most potent pharmaceutical products. Although neither product
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described in this report requires this much caution, these safety standards are used for all
operations.
All processes and products are completely isolated from each other and it can be
assumed that both the lyophilization and fluid bed granulation equipment described here
are dedicated to only one product. The operators all have sufficient personal protective
equipment such that they risk no exposure to the drugs and there are no safety concerns
for personnel. The air entering the fluid bed granulation process is filtered such that it is
sterile and safe for pharmaceutical manufacturing.
The main product quality constraint for the fluid bed granulation process is the
percent of loss on drying for which there is a process maximum and a final constraint. Loss
of drying is an important variable because the purpose of fluid bed granulation is to
improve flowability and compressibility. If the granulation product is too dry or too wet,
then these properties will not be improved and the downstream manufacturing processes
will be compromised. In order to ensure that the product falls within quality constraints,
the controlled inputs need to be carefully controlled.
The main product quality constraint for the lyophilization process is the peak
product temperature, which is the maximum temperature reached by any product vial in a
single batch during primary drying. The peak product temperature for this process has
been assumed to be -20C. The peak product temperature must be a sufficient amount
cooler than the collapse temperature, which is the temperature at which the product cake
will crack and collapse, rendering it useless. At the collapse temperature the actual drug
will most likely still be functional and maintain its desired physical properties. At slightly
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higher temperatures it is very possible that the active pharmaceutical ingredient will
denature, changing the entire identity of the drug. The risk of this occurring is far too
dangerous, thus the collapse temperature is used as a benchmark rather than the
temperature at which denaturation occurs. By using a peak product temperature
constraint that is lower than the collapse temperature, the risk of producing a denatured
product is essentially eliminated (Ward, 2019).
22.3 Food and Drug Administration Regulations
The Food and Drug Administration (FDA) has outlined three important product
tests that must be run for lyophilized products. Dose uniformity testing includes two
separate tests: content uniformity and weight variation. In these tests, the potency of the
dose should be determined by reconstituting the sample and performing an assay without
knowing the weight. In a separate test, the weight of the sample should be measured, and
the results of both tests should be correlated with each other. Stability testing is required to
determine the amount of moisture present in the vials. This test must be performed to
determine the expiration date of the drug. Worst case scenario results should always be
shown on the label, i.e. the highest moisture content and therefore earliest expiration date.
Sterility testing must confirm that the lyophilized product is completely sterile. Lyophilized
products are typically reconstituted in sterile water for injection before being administered
intravenously to the patient, so it is of the utmost importance that the lyophilized product
shows no signs of contamination. Other product inspection tests that should be performed
include determination of correct volume of cake, cake appearance, and solubility (Office of
Regulatory Affairs).
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For fluid bed granulation, the FDA has initiated a particle analytical technology
initiative. This allows for operators to determine the particle size of the product while the
operation is running. A few methods have been introduced, which include image analysis,
near-infrared spectroscopy, acoustic-emission spectroscopy, focused-beam reflectance
spectroscopy, and spatial-filter velocimetry for real-time granulation (Pharmaceutical
Technology). These methods are supposed to be more advanced and more efficient than
traditional methods used to determine particle size, like laser diffraction and sieve analysis.
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Section 23: Conclusions
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The process of fluid bed granulation was able to be further optimized. Reducing the
phase duration and slightly increasing the power requirements for each piece of equipment
resulted in operational cost savings. The following recommendations have been listed in
Table 23.1.
Table 23.1 – Recommended process parameters for fluid bed granulation

Control Inputs

Value

Inlet Air Flow Rate

2800

Inlet Air Spraying Temperature

55˚C

Inlet Air Drying Temperature

75˚C

Humidity

1-20

End Time

124 (min)

Binder Spray Rate

900 𝑠

𝑚3
ℎ𝑟

𝑘𝑔 𝑤𝑎𝑡𝑒𝑟
𝑘𝑔 𝑎𝑖𝑟

𝑔

Further research should be done into the optimization of these inputs. The “blackbox” MATLAB model did not account for any controls. A series of assumptions needed to be
made in order to complete this project.
For the lyophilization process, our recommendation is to run the primary drying
process for both 8R vials and 20 mL vials with a chamber pressure of 30 Pa, an initial
chamber temperature of -9˚C, and a final chamber temperature of 1˚C. For the 8R vial
product, the batch size will be 60,000 vials and the process time will be 16.6 hours. For the
20 mL vial product, the batch size will be 50,000 vials and the process time will be 15.6
hours. These conditions meet all of the product constraints and equipment constraints
while decreasing operational cost. The main form of savings in both cases is due to
decreased process time which reduces the amount of money that is spent on labor. The
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batch size for the 20 mL vials also increased by 10,000 from the base case to the new case
so that fewer batches need to be run every year.
Similar to the fluid bed granulation process, many assumptions were made in order
to determine the best operational conditions. Further research must be done to confirm the
viability of these conditions.
Based on the proposed conditions, $31,136 and $23,500 in operational annual
savings were identified for fluid bed granulation and lyophilization respectively. On a per
batch basis, cost savings were much higher for lyophilization due to lower batch
requirements. The main cost drivers behind this reduction were process run time in both
cases along with higher shelf temperatures for lyophilization and lower inlet airflow rate
for FBG. A sensitivity analysis on the effect of the NPV of these scenarios showed minimal
further gains in profitability for conditions significantly cheaper than our proposed.
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Section 26.1 Project Problem Statement
You are a sub-team of “Future API Manufacturing Excellence” (FAME), a strategy
group within a major pharmaceutical company, which is focused on developing business
cases for potential high-impact technologies. You have partnered with another, internal
group who has come up with a mathematical model of a crucial part of the lyophilization
process, the ‘primary drying’ step, which allows you to simulate key characteristics, such as
the drying time and maximum product temperature (a feature related to quality) in silico.
They have also created a mathematical model of the fluid bed granulation process, which
allows you to simulate it and get the drying time (note that the spraying time will depend
on the solution quantity, which is fixed, and the spray rate, which you should optimize) and
maximum product moisture (which is related to product quality). You will be given access
to the model and required to stay within the maximum product moisture design space as
you optimize the granulation. You will be given access to both “black box” models.
For lyophilization, your objective is to design a faster and/or cheaper process that
satisfies all constraints (product quality and equipment capability) for a new compound,
HAJVANOX, for which the existing process is suspected to be suboptimal. The cost
calculation obviously should include items such as the energy cost associated with the low
pressures and temperatures.
For fluid bed granulation, your objective is to optimize the granulation of a highvolume product, Botilioxin. Your goal is to find a global optimum in cost of running the fluid
bed granulator considering the energy cost of heating and blowing the air, the electricity
required to pump the spray, the depreciation of the equipment, labor cost, etc.
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For both processes, the cost estimates should also include things like, labor,
depreciation of equipment etc. and the outcome should be compared to the current base
case processes which will be supplied to you. 22 Specifically, you should calculate the
change in NPV for your design for lyophilization compared to the base case, and for fluid
bed granulation compared to its base case. If your design involves additional capital
expenditures beyond the base case design, calculate the incremental IRR on that
incremental investment. You should also study the sensitivity of the business cases towards
external factors such as the demand forecast, raw material cost, retail price of the final
product, etc.

Section 26.2 Code Snippets
Both simulations were run using “black-box” MATLAB code. A short snippet of code is
taken from each black-box model and shown below.
Section 26.2.1 Fluid Bed Granulation Code Snippet
function standalone_fbg(U, fileName)
load('FBGUIdata') % load db

%% set up model
const = varconst();

% material parameters and props
mat = product(4); % product is an array of structures stored in FBGUIdata.mat
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% process ICs and BCs
proc = ... % some calculations

% equip
equip = ... % some calculations
% set input matrix
U_str = U;
U = str2num(U); %#ok<ST2NM> input comes in as string that needs to be converted first

U(:,2) = ... % change to SI units

%% run model
[T,LOD] = FBG_main(const, equip, mat, proc, U);
%% extract outputs
% maxLOD
[maxLOD, I] = max(LOD);
maxLOD_time = T(I);

% end of process LOD
endLOD = LOD(end);
endLOD_time = T(end);

% output cell
A = {U_str, maxLOD_time/60, maxLOD*100, endLOD_time/60, endLOD * 100};

%% write
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if nargin < 2 || isempty(fileName)
% create a new file
fileName = ['fbgOutput_',char(datetime('now','format','ddMMyy_HHmmss')),'.csv'];
initiateOutputFile(fileName) % create file and add headers

else
if strcmpi(fileName(end-3:end),'.csv')
if ~exist(fileName,'file')
% file doesn't exist yet, so we must initiate it
initiateOutputFile(fileName)
end
else
error('standalone_lyo:fileNameNotCsv',...
'Output must be written to .csv file.');
end
end

fid = fopen( fileName, 'a' );
fprintf( fid, '%s,%d,%d,%d,%d\n', A{:} );
fclose( fid );

Section 26.2.2 Lyophilization Code Snippet

function standalone_lyo(U, vialGroup, vialType, fileName)
load('models') % load class instances lyo_model1 and lyo_model2

%% set up model
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% vial type
if ~ismember(vialType,{'8R','20ml'})
error('standalone_lyo:invalidVialType',...
'Input vialGroup must be one of the following: ''8R'', ''20ml''.');
end
switch vialType
case {'8R'}
L = lyo_model1; % this class instance contains constants and parameters associated
with 8R vials
case {'20ml'}
L = lyo_model2; % this class instance contains constants and parameters associated
with 20ml vials
end

% set input matrix in class instance
L.procMat.U = str2num(U); %#ok<ST2NM> input comes in as string that needs to be
converted first

%% run model
if ~ismember(vialGroup,{'center','corner','edge'})
error('standalone_lyo:invalidVialGroup',...
'Input vialGroup must be one of the following: ''center'', ''corner'', ''edge''.');
end
L.runPrimary(vialGroup); % vialGroup must be \in {‘center’,’corner’,’edge’}

%% extract outputs
% drying time
Idry = find(abs(L.output.(vialGroup).X(:,2)-100)<0.1,1,'first'); % >=99.9% of water
removed is considered dry
if ~isempty(Idry)
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tdry = L.output.(vialGroup).time(Idry);
else
tdry = inf; % no dry condition reached within time period
Idry = size(L.output.(vialGroup).X,1);
end
% peak product temperature
Tp = L.output.(vialGroup).X(1:Idry,1); % only check during active drying phase
maxTp = max(Tp);

% peak sublimation rate for one vial
SR = ... % calculating sublimation rate at each time point
maxSR = max(SR);

% output cell
A = {U, vialGroup, vialType, tdry, maxTp, maxSR};
%% write
if nargin < 4 || isempty(fileName)
% create a new file with default filename
fileName = ['lyoOutput_',char(datetime('now','format','ddMMyy_HHmmss')),'.csv'];

initiateOutputFile(fileName) % create file and add headers

else
if strcmpi(fileName(end-3:end),'.csv')
if ~exist(fileName,'file')
% file doesn't exist yet, so we must initiate it

141

initiateOutputFile(fileName)
end
else
error('standalone_lyo:fileNameNotCsv',...
'Output must be written to .csv file.');
end
end

% append to file
fid = fopen( fileName, 'a' );
fprintf( fid, '%s,%s,%s,%d,%d,%d\n', A{:} );
fclose( fid );

Section 26.3 Equipment Design Calculations
Section 26.3.1. Fluid Bed Granulation Equipment Design Equations
All of the equations noted in this section were pulled from the Product and Process Design
Principles textbook (Seider, Warren, et al. Product and Process Design Principles: Synthesis,
Analysis, and Evaluation).

Heat Exchanger/Condenser
All equations in this section were used to size and cost the heat exchanger, HX-01, and the
condenser, CD-01.
These two equations were used to determine the amount of heat required from the steam
to heat the ambient air entering the process
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𝑄̇ 𝑖𝑛 = 𝑄̇ 𝑜𝑢𝑡
𝑄̇ = 𝑚̇𝐶𝑝 𝑇

The log mean temperature was used to determine the overall heat transfer coefficient, U,
and the area for heat transfer, A.
Tlm =

(𝑇1 − 𝑇2 )
𝑇
𝑙𝑛 𝑇1
2

This equation was used to determine the overall area for heat transfer within the HX-01
unit.

𝐴=

𝑄̇
𝑈 ∗ Tlm ∗ 𝐹𝑇 {𝑅, 𝑆}

The R and S values were calculated to help determine the efficiency of the heat exchanger.
These values are based off of the inlet and outlet temperatures of the steam and ambient
air. These values go into the FT value stated above.
𝑅=

𝑇ℎ𝑜𝑡 𝑖𝑛 − 𝑇ℎ𝑜𝑡 𝑜𝑢𝑡
𝑇𝑐𝑜𝑙𝑑 𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛

𝑆=

𝑇𝑐𝑜𝑙𝑑 𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛
𝑇ℎ𝑜𝑡 𝑖𝑛 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛
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This equation was used to determine the cross-sectional area of the tubes of the heat
exchanger. This value depends on the density of the air, velocity of the air, and the mass
flow rate.
𝐴𝑐𝑖 =

𝑚𝑖
𝑖 𝑢𝑖

This equation was used to determine the number of tubes required inside the heat
exchanger. It was determined that the HX did not require any more than one tube.
𝑁𝑡 =

4𝐴𝑐𝑖
𝐷𝑖2

Area of the tubes required.
𝐴𝑡 = 𝐷𝑖 𝐿
Number of passes needed for the HX. Only one pass was needed.
𝑁𝑝 =

𝐴𝑖
𝐴𝑡 𝑁𝑡

This equation was used to calculate the base cost for the heat exchanger. This base cost is
based off of the area of heat transfer required.
𝐶𝐵 = 𝑒 11.4185−0.9228∗ln(𝐴)+0.09861(ln(𝐴)

2)

𝐶𝐵(𝐻𝑋−01) = $1,418,753.60
𝐶𝐵(𝐶𝐷−01) = $12,006,523.71
This equation is used to determine the purchase cost of the heat exchanger. It is based off of
the base cost, 𝐶𝐵 , and three other variables. These three other variables originate from the
length of the HX, the material of construction, and the pressure it operates at. All of the
multipliers used to calculate the cost of purchase were the same for the heat exchanger and
condenser used in this process.
𝐶𝑃 = 𝐶𝐵 𝐹𝑀 𝐹𝐿 𝐹𝑃

144

𝐶𝑃(𝐻𝑋−01_ = $5,776,320.53
𝐶𝑃(𝐶𝐷−01) = $48,040,246.57
FM is based off of two constants, a and b. These constants correspond to the material of
construction for the heat exchanger. The material of construction was stainless steel for the
shell and the tube side. The constants used are listed below.
𝐹𝑀 = 𝑎 + (

𝐴 𝑏
)
100

𝑎 = 2.7
𝑏 = 0.07

The FM multiplier used is listed below.
𝐹𝑀 = 3.31
Fp is based off of the pressures that the heat exchanger operates at. Both the heat
exchanger and condenser for this process operated at a pressure of P=14.7 psig.
𝑃
𝑃 2
𝐹𝑃 = 0.9803 + 0.018 (
) + 0.0017(
)
100
100
The FP multiplier is listed below.
𝐹𝑃 = 0.98
The FL multiplier is based off the length of the heat exchanger. The value listed below
corresponds to a tube length of 8ft. This is the smallest length that could be used in order to
size the heat exchanger. It was recognized that due to the size of this process, the type of
heat exchanger needed would be much smaller than this. Therefore, the smallest value
available was used.
𝐹𝐿 = 1.25
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Heater
This equation was used to determine the heat required to heat up water to steam.
𝑄̇ = 𝑚̇𝐶𝑝 𝑇
This equation was used to calculate the amount of heat needed to heat up 10˚C water to
140˚C steam. This includes the Heat of Vaporization needed in order for water to turn to
steam. The value of 𝐻𝑣𝑎𝑝 was found to be 40.66 kJ/mol.

𝑄̇ (

100˚𝐶
100˚𝐶
𝑘𝐽
)=∫
𝐶𝑝(𝐻2 𝑜(𝑙)) 𝑑𝑇 + 𝐻𝑣𝑎𝑝 + ∫
𝐶𝑝(𝐻2 𝑂(𝑔)) 𝑑𝑇
𝑚𝑜𝑙
10˚𝐶
10˚𝐶

𝑄̇ = 44.42(

𝑘𝐽
)
𝑚𝑜𝑙

The power that was required from the heater was calculated using this equation. The mass
flow rate of the water is multiplied by the heat required for the process. This gives the total
power required in kJ/s.
𝑘𝐽
𝑃𝑜𝑤𝑒𝑟( ) = 𝑄̇ 𝑚̇
𝑠
𝑘𝐽
𝑘𝐽
𝑚𝑜𝑙
𝑃𝑜𝑤𝑒𝑟 ( ) = 44.42(
) ∗ 25.79 (
)
𝑠
𝑚𝑜𝑙
𝑠
𝑘𝐽
𝑃𝑜𝑤𝑒𝑟 = 1145.8 ( )
𝑠

Fan
In order to calculate the power required from the fan, the pressure head and head in. H2O
needed to be calculated. Calculating these values help determine the multipliers that
required for the purchase cost of the fan. All these equations were pulled from
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Equation used to calculate the pressure head. It was assumed the fan operated at pressures
slightly below atmospheric.
780 − 𝑃
( 760 ) ∗ 14.7 ∗ 144
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑 =
. 0644
Equation used to determine the Head in. H2O required for this process.
𝐻𝑒𝑎𝑑 𝑖𝑛. 𝐻2 𝑂 =

𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑
∗ .1924
17.23

𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑 = 19.31 (𝑖𝑛. 𝐻2 𝑂)

This Q is the flow rate of air required for the process.
𝑓𝑡 3
𝑚3
𝑄 = 4927
= 2800
𝑚𝑖𝑛
ℎ𝑟
This FM multiplier corresponds with the material of construction. For stainless steel, the
multiplier is listed below.
𝐹𝑀 = 2.5
The value of FH corresponds to Head (in. H2O) calculated above. Since total Head was
determined to be 19.31, the FH value is 1.45.
𝐹𝐻 = 1.45
The base cost multiplier is based on the flow rate of air required for the process, which is
2800 (m3/hr).
2)

𝐶𝐵 = 𝑒 11.4152−1.3805∗ln(𝑄)+0.1139(ln(𝑄)
𝐶𝐵 = $2,728.80
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The purchase cost of the fan is the multiplication of all the multipliers listed above.

𝐶𝑃 = 𝐶𝐵 𝐹𝑀 𝐹𝐻
𝐶𝑃 = $9.891.90
The power required for this process was calculated using the equation below. It is based off
of the flow rate (Q), Head (H), motor efficiency (nm), and fan efficiency (nf). It was assumed
that the fan efficiency was 0.6 and the motor efficiency was 0.9.
𝑃𝑜𝑤𝑒𝑟 (𝑘𝑊) =

𝑄𝐻
∗ 0.7457
6350𝑛𝑓 𝑛𝑚

𝑃𝑜𝑤𝑒𝑟 = 25.58 (𝑘𝑊)

Pump
The pump required for this process is a peristaltic pump. There were no equipment
calculations available in order to size or cost this piece of equipment. As recommend by the
project author, research was done on a series of peristaltic pumps typically used in
pharmaceutical processes. It was determined that the best option was one manufactured
by Verdor Flex. The pump chosen operates at atmospheric pressures and has a maximum
flow rate of 1.7 (L/min). For the fluid bed granulation process, the flow rate of binder
required was 0.89 (L/min). The pump chosen falls within the specs needed for the process.
The estimated cost for this type of pump is around $300-$500. Additional cost for this
pump would be incurred through the replacement of tubes needed for the pump.
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Filters
Similar to the pump needed for the process, there does not exists a sizing or costing
resources for the filters required for the process. A possible vendor found was Advanced
Filtration Concepts. They manufacture and sell filters typically used for processes that
require the highest standard of sterilization. A HV HEPA Filter was determined to be the
best option for this process. Its specs fall within the particle size of what needs to be
removed from the air in addition to keeping the product inside the process. Their smallest
filter with dimensions of 12’’x24’’x11.5’’ would be the best option for this process.

Section 26.3.2 Lyophilization Equipment Design Equations
Heater Design Calculations
Because the process is operating at extremely low pressures, it is expected that any heat
transfer due to convection will be negligible. Compared to heat due to conduction and the
heat of sublimation of ice, the heat of radiation was also negligible. The heat duty of the
heater was calculated by determining the amount of energy required to change the
temperature of the stainless steel shelves, the glass vials, and the product within the vial as
well as adding the heat required to sublimate the ice.
The heat required to increase the temperature of the shelves in the chamber is given by:

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠 = 𝑚 ∗ 𝐶𝑝,𝑠𝑡𝑒𝑒𝑙 ∗ ∆𝑇
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Assuming 10 large stainless steel shelves with a thickness of 5 mm and dimensions of 1550
mm x 1600 mm, the total shelf mass can be calculated as follows:

𝑚𝑠ℎ𝑒𝑙𝑣𝑒𝑠 (𝑘𝑔) = 10 ∗ 1.55 𝑚 ∗ 1.6 𝑚 ∗ 0.005 𝑚 ∗ 2 ∗ 7900

𝑘𝑔
= 1959.2 𝑘𝑔
𝑚3

The temperature change from -45˚C (228 K) to T1:

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1 (𝑘𝐽) = 1959.2 𝑘𝑔 ∗ 439.5

𝐽
𝑘𝐽
∗ (𝑇1 − 228 𝐾) ∗ 0.001
𝑘𝑔 ∗ 𝐾
𝐽

The temperature change occurs over a period of 1.5 hours so power can be calculated as
follows:

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1 (𝑘𝑊) =

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1 (𝑘𝐽)
𝑠𝑒𝑐
1.5 ℎ𝑟 ∗ (3600
)
ℎ𝑟

The temperature change from T1 to T2:

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2 (𝑘𝐽) = 1959.2 𝑘𝑔 ∗ 439.5

𝐽
𝑘𝐽
∗ (𝑇2 − 𝑇1 𝐾) ∗ 0.001
𝑘𝑔 ∗ 𝐾
𝐽

The temperature change occurs over a period of 1.5 hours so power can be calculated as
follows:

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2 (𝑘𝑊) =

𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2 (𝑘𝐽)
𝑠𝑒𝑐
1.5 ℎ𝑟 ∗ (3600
)
ℎ𝑟
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Table 26.3.2.1. Heat duty for shelves.

8R Vial

20 mL Vial

Base Case

30,137 kJ

30,137 kJ

New Case

39,609 kJ

39,609 kJ

Table 26.3.2.2. Power for shelf heating.

8R Vial

20 mL Vial

Base Case

5.58 kW

5.58 kW

New Case

7.34 kW

7.34 kW

𝑄𝑣𝑖𝑎𝑙𝑠 = 𝑁 ∗ 𝑚 ∗ 𝐶𝑝,𝑏𝑜𝑟𝑜𝑠𝑖𝑙𝑖𝑐𝑎𝑡𝑒 ∗ ∆𝑇
Where N= number vials
The mass, volume, and heat capacity of both vial types are given by the Schott
Pharmaceutical Packaging Manual (Schott):
Schott borosilicate 8R vial
Mass: 8.7 g
Volume: 10 mL
Cp= 830 J/kg*K

Schott borosilicate 20 mL vial
Mass: 16.2 g
Volume: 20 mL
Cp= 830 J/kg*K

Similarly to the shelves, the temperature change from -45˚C (228 K) to T1:

𝑄𝑣𝑖𝑎𝑙𝑠,1 (𝑘𝐽) = 𝑁 ∗ 𝑚𝑣𝑖𝑎𝑙 (𝑘𝑔) ∗ 830

𝐽
𝑘𝐽
∗ (𝑇1 − 228 𝐾) ∗ 0.001
𝑘𝑔 ∗ 𝐾
𝐽
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The temperature change occurs over a period of 1.5 hours so power can be calculated as
follows:

𝑄𝑣𝑖𝑎𝑙𝑠,1 (𝑘𝑊) =

𝑄𝑣𝑖𝑎𝑙𝑠,1 (𝑘𝐽)
𝑠𝑒𝑐
1.5 ℎ𝑟 ∗ (3600
)
ℎ𝑟

The temperature change from T1 to T2:

𝑄𝑣𝑖𝑎𝑙𝑠,2 (𝑘𝐽) = 𝑁 ∗ 𝑚𝑣𝑖𝑎𝑙 (𝑘𝑔) ∗ 830

𝐽
𝑘𝐽
∗ (𝑇2 − 𝑇1 𝐾) ∗ 0.001
𝑘𝑔 ∗ 𝐾
𝐽

The temperature change occurs over a period of 1.5 hours so power can be calculated as
follows:
𝑄𝑣𝑖𝑎𝑙𝑠,2 (𝑘𝑊) =

𝑄𝑣𝑖𝑎𝑙𝑠,2 (𝑘𝐽)
𝑠𝑒𝑐
1.5 ℎ𝑟 ∗ (3600
)
ℎ𝑟

Table 26.3.2.3. Heat duty for vials.

8R Vial

20 mL Vial

Base Case

15,164 kJ

18,824 kJ

New Case

19,930 kJ

30,926 kJ

8R Vial

20 mL Vial

Base Case

2.81 kW

3.49 kW

New Case

3.69 kW

5.73 kW

Table 26.3.2.4. Power for vial heating.
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At each different pressure, the sublimation temperature, Tsub (K), was calculated using the
following equation
𝑃𝑖𝑐𝑒 (𝑃𝑎) = exp(9.550426 −

5723.265
+ 3.53068 ∗ ln(𝑇𝑠𝑢𝑏 ) − 0.00728332𝑇𝑠𝑢𝑏 )
𝑇𝑠𝑢𝑏

Sublimation temperatures were calculated for the following pressures:
Table 26.3.2.5. Ice sublimation temperatures.

P (Pa)

Tsub (K)

10

230.95844

20

237.13047

26

239.55344

30

240.89595

40

243.64092

The energy required to heat the ice from -45˚C (228 K) to the sublimation temperature is
given by:

𝑄𝑖𝑐𝑒 (

𝑇𝑠𝑢𝑏
𝐽
1 𝑚𝑜𝑙
𝑔
)=
∗ 1000
∗∫
𝐶
𝑑𝑇
𝑘𝑔
18.02 𝑔
𝑘𝑔 228 𝐾 𝑝,𝑖𝑐𝑒

Where the heat capacity of ice is given by:

𝐶𝑝,𝑖𝑐𝑒 (

𝑇 2
𝐽
) = −2.0572 + 0.14644𝑇 + 0.06163𝑇𝑒 (−(125.1) )
𝑚𝑜𝑙 ∗ 𝐾

The heat of sublimation is given by:

𝐻𝑠𝑢𝑏 (

𝑇
𝐽
2
) = 46782.5 + 35.8925𝑇 − 0.07414𝑇 2 + 541.5𝑒 (−(123.75) )
𝑚𝑜𝑙
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𝐽
1 𝑚𝑜𝑙
𝑔
𝐽
𝐻𝑠𝑢𝑏 ( ) =
∗ 1000
∗ 𝐻𝑠𝑢𝑏 (
)
𝑘𝑔
18.02 𝑔
𝑘𝑔
𝑚𝑜𝑙
The energy required to heat the vapor from the sublimation temperature (Tsub) to T2 is
given by:
𝑇2
𝐽
1 𝑚𝑜𝑙
𝑔
𝑄𝑣𝑎𝑝𝑜𝑟 ( ) =
∗ 1000
∗∫ 𝐶
𝑑𝑇
𝑘𝑔
18.02 𝑔
𝑘𝑔 𝑇𝑠𝑢𝑏 𝑝,𝑣𝑎𝑝𝑜𝑟

Where the heat capacity of vapor is given by 1:

𝐶𝑝,𝑣𝑎𝑝𝑜𝑟 (

𝑇
𝐽
2
) = −35.319 + 0.14457𝑇 + 0.06155𝑇𝑒 (−(129.85) )
𝑚𝑜𝑙 ∗ 𝐾

The total heat required for the ice is given by:

𝑄𝑖𝑐𝑒 (

𝐽
𝐽
𝐽
) = 𝑄𝑖𝑐𝑒 ( ) + 𝐻𝑠𝑢𝑏 (𝑇𝑠𝑢𝑏 ) + 𝑄𝑣𝑎𝑝𝑜𝑟 ( )
𝑘𝑔
𝑘𝑔
𝑘𝑔

Given that the vials contain 88-95% water before freeze drying, it is assumed that each vial
contains 91.5% water. It is also assumed that all water will be sublimated off during
primary drying.
For the 8R vial product, the amount of water present in each vial is given by:

𝑀𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 (𝑘𝑔) = 10 𝑚𝐿 ∗ 0.915 ∗ 1

𝑔
𝑘𝑔
∗ 0.001
= 0.0087 𝑘𝑔
𝑚𝐿
𝑔

To get the total amount of water that is being sublimated, multiply the mass of water per
vial by N, the total number of vials.
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𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) = 𝑁 ∗ 0.0087 𝑘𝑔

For the 20 mL vial product, the amount of water present in each vial is given by:

𝑀𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 (𝑘𝑔) = 20 𝑚𝐿 ∗ 0.915 ∗ 1

𝑔
𝑘𝑔
∗ 0.001
= 0.0183 𝑘𝑔
𝑚𝐿
𝑔

To get the total amount of water that is being sublimated, multiply the mass of water per
vial by N, the total number of vials.

𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) = 𝑁 ∗ 0.0183 𝑘𝑔

The heat duty for sublimation can be calculated by:

𝐻𝑒𝑎𝑡 𝑑𝑢𝑡𝑦 𝑜𝑓 𝑖𝑐𝑒 (𝑘𝐽) = 𝑄𝑖𝑐𝑒 (

𝐽
𝐽
) ∗ 𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) ∗ 0.001
𝑘𝑔
𝑘𝐽

Table 26.3.2.6. Heat duty for ice heating and sublimation

8R Vial

20 mL Vial

Base Case

1.57*106 kJ

1.05*106 kJ

New Case

1.57*106 kJ

1.31*106 kJ

To get the average rate of sublimation, divide the total mass of water by the total process
time.

𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑅𝑎𝑡𝑒 𝑜𝑓 𝑆𝑢𝑏𝑙𝑖𝑚𝑎𝑡𝑖𝑜𝑛 (

𝑘𝑔
𝑡𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔)
)=
ℎ𝑟
𝑡𝑜𝑡𝑎𝑙 𝑝𝑟𝑜𝑐𝑒𝑠𝑠 𝑡𝑖𝑚𝑒 (ℎ𝑟)

To get the total power used to heat and sublimate the ice:
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𝐽
𝑘𝑔
𝐽
𝑄𝑖𝑐𝑒 (𝑘𝑊) = 𝑄𝑖𝑐𝑒 ( ) ∗ 𝐴𝑣𝑔 𝑆𝑢𝑏 𝑅𝑎𝑡𝑒 ( ) ∗ 0.001
𝑘𝑔
ℎ𝑟
𝑘𝐽
Table 26.3.2.7. Power for ice heating and sublimation.

8R Vial

20 mL Vial

Base Case

17.3 kW

13.3 kW

New Case

26.3 kW

23.3 kW

In table 26.3.2.8, all of the previously calculated heat duties are added together to get the
total heat duty required by the electric heater.
Table 26.3.2.8. Total required heat duty for electric heater.

8R Vial

20 mL Vial

Base Case

1.62*106 kJ

1.10*106 kJ

New Case

1.63*106 kJ

1.38*106 kJ

In table 26.3.2.9, the previously calculated powers are added together to get the total
power required by the electric heater.
Table 26.3.2.9. Total required power for electric heater.

8R Vial

20 mL Vial

Base Case

25.7 kW

22.3 kW

New Case

37.3 kW

36.4 kW

The heater has an efficiency of 90%. Table 26.3.2.10 shows the total required power for the
electric heater after taking the efficiency factor into account.
Table 26.3.2.10 Total required power with 90% efficiency.

8R Vial

20 mL Vial

Base Case

28.6 kW

24.8 kW

New Case

41.4 kW

40.4 kW

Condenser Design Calculations
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The condenser is a stainless steel cooling coil with cold silicon oil at -55˚C flowing through
it. The silicon oil must be able to absorb heat from the stainless steel condenser surface.
The condenser will mainly absorb heat through deposition of water vapor to ice. Radiation
and convection are negligible in comparison to the heat duty required by ice deposition.
The condenser must first undergo a temperature change from -45˚C to -55˚C which will
take approximately 1.5 hours.
Assuming the condenser uses 1 inch tubing (Seider):
ID= 0.622 in (0.0158 m)
OD= 0.84 in (0.0213 m)
Length= 16.5 m

The volume of the stainless steel condenser is given by

𝑉𝑜𝑙𝑢𝑚𝑒𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑚3 ) = 𝜋 ∗ 16.5 𝑚 ∗ ((

0.0213 2
0.0158 2
𝑚) − (
𝑚) ) = 0.00266 𝑚3
2
2

𝑀𝑎𝑠𝑠𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑘𝑔) = 7900

𝑘𝑔
∗ 0.00266 𝑚3 = 21.05 𝑘𝑔
3
𝑚

The heat that the condenser must absorb in order to decrease in temperature from -45˚C
(228 K) to -55˚C (218 K) is given by:

𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 = 𝑚𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 ∗ 𝐶𝑝,𝑠𝑡𝑒𝑒𝑙 ∗ (218 − 228 𝐾)

𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑘𝐽) = 𝑚𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 ∗ 439.5

𝐽
𝐽
∗ (218 − 228 𝐾) ∗ 0.001 = −92.5 𝑘𝐽
𝑘𝑔 ∗ 𝐾
𝑘𝐽
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The temperature change will occur over a period of 1.5 hours so the power that must be
removed by the refrigeration system is given by:
𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑘𝑊) =

𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑘𝐽)
𝑠𝑒𝑐 = −0.0171 𝑘𝑊
1.5 ℎ𝑟 ∗ (3600
)
ℎ𝑟

The heat required to cool the vapor to the deposition temperature (Tdep) is given by:
𝑇𝑑𝑒𝑝
𝐽
1 𝑚𝑜𝑙
𝑔
𝑄𝑣𝑎𝑝𝑜𝑟 ( ) =
∗ 1000
∗ ∫
𝐶𝑝,𝑣𝑎𝑝𝑜𝑟 𝑑𝑇
𝑘𝑔
18.02 𝑔
𝑘𝑔
𝑇2

Where:
𝑇

2)

𝐶𝑝,𝑣𝑎𝑝𝑜𝑟 = −35.319 + 0.14457𝑇 + 0.06155𝑇𝑒 (−(129.85)
The heat given off from deposition is given by:

𝑇
𝐽
2
𝐻𝑑𝑒𝑝 (
) = −(46782.5 + 35.8925𝑇 − 0.07414𝑇 2 + 541.5𝑒 (−(123.75) ) )
𝑚𝑜𝑙

𝐽
1 𝑚𝑜𝑙
𝑔
𝐽
𝐻𝑑𝑒𝑝 ( ) =
∗ 1000
∗ 𝐻𝑑𝑒𝑝 (
)
𝑘𝑔
18.02 𝑔
𝑘𝑔
𝑚𝑜𝑙
The heat that must be removed to decrease the temperature of the ice from Tsub to -45˚C
(228 K) is given by:

228 𝐾
𝐽
1 𝑚𝑜𝑙
𝑔
𝑄𝑖𝑐𝑒 ( ) =
∗ 1000
∗ ∫
𝐶𝑝,𝑖𝑐𝑒 𝑑𝑇
𝑘𝑔
18.02 𝑔
𝑘𝑔
𝑇𝑑𝑒𝑝

Where:
𝑇

2)

𝐶𝑝,𝑖𝑐𝑒 = −2.0572 + 0.14644𝑇 + 0.06163𝑇𝑒 (−(125.1)
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The total heat that must be removed to decrease the temperature of the vapor, depose the
vapor, and decrease the temperature of the ice is given by:
𝑄𝑖𝑐𝑒 (

𝐽
𝐽
𝐽
) = 𝑄𝑖𝑐𝑒 ( ) + 𝐻𝑑𝑒𝑝 (𝑇𝑑𝑒𝑝 ) + 𝑄𝑣𝑎𝑝𝑜𝑟 ( )
𝑘𝑔
𝑘𝑔
𝑘𝑔

The heat duty required to depose the ice can be calculated as follows:
𝐻𝑒𝑎𝑡 𝑑𝑢𝑡𝑦 𝑜𝑓 𝑖𝑐𝑒 (𝑘𝐽) = 𝑄𝑖𝑐𝑒 (

𝐽
𝐽
) ∗ 𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) ∗ 0.001
𝑘𝑔
𝑘𝐽

Table 26.3.2.11. Heat duty for ice cooling and sublimation.

8R Vial

20 mL Vial

Base Case

-1.58*106 kJ

-1.05*106 kJ

New Case

-1.58*106 kJ

-5.28*105 kJ

The average rate of deposition must be the same as the average rate of sublimation, so that
the required power of refrigeration is given by:
𝐽
𝑘𝑔
𝐽
𝑄𝑖𝑐𝑒 (𝑘𝑊) = 𝑄𝑖𝑐𝑒 ( ) ∗ 𝐴𝑣𝑔 𝑆𝑢𝑏 𝑅𝑎𝑡𝑒 ( ) ∗ 0.001
𝑘𝑔
ℎ𝑟
𝑘𝐽

Table 26.3.2.12. Power for ice cooling and sublimation.

8R Vial

20 mL Vial

Base Case

-17.4 kW

-13.4 kW

New Case

-26.5 kW

-8.83 kW

Combining these results with the heat duty and power requirements for the condenser
above, we can calculate total heat duty and power requirements.
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Table 26.3.2.13. Total heat duty required by condenser.

8R Vial

20 mL Vial

Base Case

-1.58*106 kJ

-1.05*106 kJ

New Case

-1.58*106 kJ

-5.28*105 kJ

Table 26.3.2.14. Total power required by condenser.

8R Vial

20 mL Vial

Base Case

-17.4 kW

-13.4 kW

New Case

-26.5 kW

-8.84 kW

The refrigeration system has an efficiency of 80%. Table 26.3.2.15 shows the total required
power for the condenser after taking the efficiency factor into account.
Table 26.3.2.15. Total power required by condenser with 80% efficiency factor.

8R Vial

20 mL Vial

Base Case

-21.75 kW

-16.75 kW

New Case

-33.13 kW

-11.1 kW

Vacuum Pump Design Calculations
The vacuum pump is used to decrease the pressure of the lyophilization chamber from
atmospheric pressure to the extremely low pressures required by lyophilization. The
pressure is varied from 10 to 40 Pa in this project. The pump must then maintain the lower
pressure for the duration of primary drying. The price of the vacuum pump will vary
significantly depending on the operational pressure, so this is the one piece of equipment in
lyophilization that will be costed. The price of the vacuum pump is dependent on S
(ft3/min), the flow at suction. For a long process such as primary drying in lyophilization,

160

the flow rate at suction that is handled by the vacuum system is based on the air leakage
into the equipment.
The Heat Exchange Institute provides the following equation to estimate air leakage rate
based on operation pressure and chamber volume.
𝑊(

𝑙𝑏
) = 5 + {0.0298 + 0.03088[ln(𝑃)] − 0.0005733 ∗ [ln(𝑃)]2 }𝑉 0.66
ℎ𝑟

Where:
𝑊[=]

𝑙𝑏
ℎ𝑟

𝑃[=]𝑡𝑜𝑟𝑟
𝑉[=]𝑓𝑡 3

It is known that the volume of the chamber is 17,000 L or approximately 600 ft3. This
equation is only applicable for pressures above 1 torr. Because the operational pressures
are lower than 1 torr, this equation was converted to a polynomial equation and
extrapolated to include pressures below 1 torr. The polynomial equation is given as
follows:
𝑊 = −0.008𝑃4 + 0.0611𝑃3 − 0.1384𝑃2 + 0.2459𝑃 + 4.9143

This equation is used to determine the air leakage rate at different pressures. The flow at
suction, S, is determined:

𝑆=

𝑊
𝑃

Where
𝑓𝑡 3
𝑆[=]
𝑚𝑖𝑛
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The cost is based on an equation from the textbook:
𝐶𝑝 = 10,875 ∗ 𝑆 0.38
The vacuum pump will be made of stainless steel, which adds a cost multiplier of 2, so the
total purchase cost of the vacuum is given by:
𝐶𝑝 = 2 ∗ 10,875 ∗ 𝑆 0.38
The bare module factor for a pump is 3.30 and the investment site factor for a country in
Western Europe is 1.20. Thus the bare module cost of the vacuum pump is given by:
𝐶𝐵𝑀 = 3.30 ∗ 1.20 ∗ 2 ∗ 10,875 ∗ 𝑆 0.38
Table 26.3.2.15. Bare module vacuum pump cost.

8R Vial

20 mL Vial

Base Case

$284,397

$284,397

New Case

$272,406

$272,406

The operational costs of the vacuum pump can be calculated using the following equation
with inputs of W (gas flow rate), Pa (suction pressure), Pd (discharge pressure), and 𝜂𝑑 , the
adiabatic thermal efficiency of dry vacuum pumps.
𝑃 0.286
𝑊 ∗ (( 𝑑 )
− 1)
𝑃𝑎
𝑃=
12 ∗ 𝜂𝑑
Where:
𝑃[=] ℎ𝑝
𝑊[=]

𝑙𝑏
ℎ𝑟

162

𝑃𝑑 𝑎𝑛𝑑 𝑃𝑎 [=]𝑡𝑜𝑟𝑟
Table 26.3.2.16. Power required by vacuum pump.

8R Vial

20 mL Vial

Base Case

5.69 hp

5.69 hp

New Case

5.44 hp

5.44 hp

Section 26.4 Fluid Bed Granulation Simulation Results
Below are the simulations that were run throughout the duration of this project.
With the help of the abbreviated full-factorial method mentioned in Section 13, these were
the first simulations run. These results helped narrow down which type of inputs we
should start with.
Sim
#
Input Matrix

Max LOD Time Max LOD End Time
[min]
[%]
[min]

End LOD
[%]

[0 46 6.2 2500 1000;100 75 6.2 2500 0;175
1 NaN NaN NaN NaN]

100

14.90

175

2.93

[0 58 6.2 2500 800;100 75 6.2 2500 0;175
2 NaN NaN NaN NaN]

100

8.26

175

0.09

[0 46 6.2 2500 800;100 75 6.2 2500 0;175
3 NaN NaN NaN NaN]

100

11.00

175

0.58

[0 58 6.2 2500 1000;100 75 6.2 2500 0;175
4 NaN NaN NaN NaN]

100

12.30

175

1.06

The only inputs changed in this set of simulations were the inlet air temperature and the
binder spray rate. Simulations 1,2, and 3 were the ones that had the LOD% values that fell
closest to the constraints required for the product. Based on these results and
recommendations from the project author, it was decided that the phase duration for the
drying step needed to be altered. The next set of simulations were run at a series of ranging
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drying temperatures—both with high and low inlet temperatures. The binder spray rate
was kept the same.
Once it was determined which range of values should be focused on, the rest of the inputs
needed to be optimized. With a recommendation from the project author, the drying phase
duration was reduced to see if that had a great effect on the end LOD% values.
Low Inlet
Temperatures
[0 46 6.2 3200 1000;100 75 6.2 3200
1 0;150 NaN NaN NaN NaN]

100

12.80

150

2.60

[0 46 6.2 3200 1000;100 75 6.2 3200
2 0;151 NaN NaN NaN NaN]

100

12.80

151

2.45

[0 46 6.2 3200 1000;100 75 6.2 3200
3 0;152 NaN NaN NaN NaN]

100

12.80

152

2.31

[0 46 6.2 3200 1000;100 75 6.2 3200
4 0;153 NaN NaN NaN NaN]

100

12.80

153

2.17

[0 46 6.2 3200 1000;100 75 6.2 3200
5 0;154 NaN NaN NaN NaN]

100

12.80

154

2.04

[0 46 6.2 3200 1000;100 75 6.2 3200
6 0;155 NaN NaN NaN NaN]

100

12.80

155

1.91

[0 46 6.2 3200 1000;100 75 6.2 3200
7 0;156 NaN NaN NaN NaN]

100

12.80

156

1.79

[0 46 6.2 3200 1000;100 75 6.2 3200
8 0;157 NaN NaN NaN NaN]

100

12.80

157

1.67

[0 46 6.2 3200 1000;100 75 6.2 3200
9 0;158 NaN NaN NaN NaN]

100

12.80

158

1.56

[0 46 6.2 3200 1000;100 75 6.2 3200
10 0;159 NaN NaN NaN NaN]

100

12.80

159

1.45

[0 46 6.2 3200 1000;100 75 6.2 3200
11 0;160 NaN NaN NaN NaN]

100

12.80
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1.34

[0 46 6.2 3200 1000;100 75 6.2 3200
12 0;161 NaN NaN NaN NaN]

100

12.80
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1.24

[0 46 6.2 3200 1000;100 75 6.2 3200
13 0;162 NaN NaN NaN NaN]

100

12.80
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1.15

[0 46 6.2 3200 800;100 75 6.2 3200 0;150
14 NaN NaN NaN NaN]

100

8.80

150

0.55

[0 46 6.2 3200 800;100 75 6.2 3200 0;151
15 NaN NaN NaN NaN]

100

8.80

151

0.48

[0 46 6.2 3200 800;100 75 6.2 3200 0;152
16 NaN NaN NaN NaN]

100

8.80

152

0.41

[0 46 6.2 3200 800;100 75 6.2 3200 0;153
17 NaN NaN NaN NaN]

100

8.80

153

0.34
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[0 46 6.2 3200 800;100 75 6.2 3200 0;154
18 NaN NaN NaN NaN]

100

8.80

154

0.28

[0 46 6.2 3200 800;100 75 6.2 3200 0;155
19 NaN NaN NaN NaN]

100

8.80

155

0.21

[0 46 6.2 3200 800;100 75 6.2 3200 0;156
20 NaN NaN NaN NaN]

100

8.80

156

0.15

[0 46 6.2 3200 800;100 75 6.2 3200 0;157
21 NaN NaN NaN NaN]

100

8.80

157

0.10

[0 46 6.2 3200 800;100 75 6.2 3200 0;158
22 NaN NaN NaN NaN]

100

8.80

158

0.09

[0 46 6.2 3200 800;100 75 6.2 3200 0;159
23 NaN NaN NaN NaN]

100

8.80

159

0.09

[0 46 6.2 3200 800;100 75 6.2 3200 0;160
24 NaN NaN NaN NaN]

100

8.80

160

0.09

[0 46 6.2 3200 800;100 75 6.2 3200 0;161
25 NaN NaN NaN NaN]

100

8.80

161

0.09

[0 46 6.2 3200 800;100 75 6.2 3200 0;162
26 NaN NaN NaN NaN]

100

8.80

162

0.09

[0 58 6.2 3200 1000;100 75 6.2 3200
27 0;150 NaN NaN NaN NaN]

100

9.32

150

0.67

[0 58 6.2 3200 1000;100 75 6.2 3200
28 0;151 NaN NaN NaN NaN]

100

9.32

151

0.60

[0 58 6.2 3200 1000;100 75 6.2 3200
29 0;152 NaN NaN NaN NaN]

100

9.32

152

0.52

[0 58 6.2 3200 1000;100 75 6.2 3200
30 0;153 NaN NaN NaN NaN]

100

9.32

153

0.45

[0 58 6.2 3200 1000;100 75 6.2 3200
31 0;154 NaN NaN NaN NaN]

100

9.32

154

0.38

[0 58 6.2 3200 1000;100 75 6.2 3200
32 0;155 NaN NaN NaN NaN]

100

9.32

155

0.32

[0 58 6.2 3200 1000;100 75 6.2 3200
33 0;156 NaN NaN NaN NaN]

100

9.32

156

0.25

[0 58 6.2 3200 1000;100 75 6.2 3200
34 0;157 NaN NaN NaN NaN]

100

9.32

157

0.19

[0 58 6.2 3200 1000;100 75 6.2 3200
35 0;158 NaN NaN NaN NaN]

100

9.32

158

0.13

[0 58 6.2 3200 1000;100 75 6.2 3200
36 0;159 NaN NaN NaN NaN]

100

9.32

159

0.09

[0 58 6.2 3200 1000;100 75 6.2 3200
37 0;160 NaN NaN NaN NaN]

100

9.32

160

0.09

[0 58 6.2 3200 1000;100 75 6.2 3200
38 0;161 NaN NaN NaN NaN]

100

9.32

161

0.09

[0 58 6.2 3200 1000;100 75 6.2 3200
39 0;162 NaN NaN NaN NaN]

100

9.32

162

0.09

[0 58 6.2 3200 800;100 75 6.2 3200 0;150
40 NaN NaN NaN NaN]

100

5.57

150

0.09

High Inlet
Temperatures
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[0 58 6.2 3200 800;100 75 6.2 3200 0;151
41 NaN NaN NaN NaN]

100

5.57

151

0.09

[0 58 6.2 3200 800;100 75 6.2 3200 0;152
42 NaN NaN NaN NaN]

100

5.57

152

0.09

[0 58 6.2 3200 800;100 75 6.2 3200 0;153
43 NaN NaN NaN NaN]

100

5.57

153

0.09

[0 58 6.2 3200 800;100 75 6.2 3200 0;154
44 NaN NaN NaN NaN]

100

5.57

154

0.09

[0 58 6.2 3200 800;100 75 6.2 3200 0;155
45 NaN NaN NaN NaN]

100

5.57

155

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;156
46 NaN NaN NaN NaN]

100

5.57

156

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;157
47 NaN NaN NaN NaN]

100

5.57

157

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;158
48 NaN NaN NaN NaN]

100

5.57

158

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;159
49 NaN NaN NaN NaN]

100

5.57

159

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;160
50 NaN NaN NaN NaN]

100

5.57

160

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;161
51 NaN NaN NaN NaN]

100

5.57

161

0.08

[0 58 6.2 3200 800;100 75 6.2 3200 0;162
52 NaN NaN NaN NaN]

100

5.57

162

0.08

After running simulations at drying temperature phases ranging from 150-162 minutes, it
was found that the product was still too dry for what is required. It was found that a few
simulations fell within the constraints, so it was decided to lower the phase duration even
more.

166

Lower Drying
Temperatures
[0 46 6.2 3200 800;100 75 6.2 3200
53 0;120 NaN NaN NaN NaN]

100

8.80E+00

120 4.66E+00

[0 46 6.2 3200 800;100 75 6.2 3200
54 0;121 NaN NaN NaN NaN]

100

8.80E+00

121 4.44E+00

[0 46 6.2 3200 800;100 75 6.2 3200
55 0;122 NaN NaN NaN NaN]

100

8.80E+00

122 4.23E+00

[0 46 6.2 3200 800;100 75 6.2 3200
56 0;123 NaN NaN NaN NaN]

100

8.80E+00

123 4.02E+00

[0 46 6.2 3200 800;100 75 6.2 3200
57 0;124 NaN NaN NaN NaN]

100

8.80E+00

124 3.82E+00

[0 46 6.2 3200 800;100 75 6.2 3200
58 0;125 NaN NaN NaN NaN]

100

8.80E+00

125 3.63E+00

[0 46 6.2 3200 800;100 75 6.2 3200
59 0;126 NaN NaN NaN NaN]

100

8.80E+00

126 3.44E+00

[0 46 6.2 3200 800;100 75 6.2 3200
60 0;127 NaN NaN NaN NaN]

100

8.80E+00

127 3.25E+00

[0 46 6.2 3200 800;100 75 6.2 3200
61 0;128 NaN NaN NaN NaN]

100

8.80E+00

128 3.07E+00

[0 46 6.2 3200 800;100 75 6.2 3200
62 0;129 NaN NaN NaN NaN]

100

8.80E+00

129 2.90E+00

[0 46 6.2 3200 800;100 75 6.2 3200
63 0;130 NaN NaN NaN NaN]

100

8.80E+00

130 2.74E+00

[0 46 6.2 3200 800;100 75 6.2 3200
64 0;131 NaN NaN NaN NaN]

100

8.80E+00

131 2.58E+00

[0 46 6.2 3200 800;100 75 6.2 3200
65 0;132 NaN NaN NaN NaN]

100

8.80E+00

132 2.43E+00

After running simulations at lower drying temperatures, ranging from 120-132 minutes, it
was found that a series of these simulations fell within the Max LOD and End LOD% values.

After presenting these findings to the project author, it was found that the inlet air
temperature chosen for these simulations were too low for the heat exchanger to reach
equilibrium quickly. In order for the process to run efficiently, the author recommended
the inlet air spraying temperature should be a maximum of 20˚C from the inlet air drying
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temperature of 75˚C. Therefore, the inlet air spraying temperature was increased to a value
of 55˚C.
The next set of simulations were ones run at an inlet air spray temperature of 55˚C.
Sim
#
Input Matrix

Max LOD
Time [min]

Max LOD
[%]

End Time
[min]

End LOD
[%]

[0 55 6.2 3200 900;100 75 6.2 3200
1 0;120 NaN NaN NaN NaN]

100

8.22E+00

120

3.98E+00

[0 55 6.2 3200 900;100 75 6.2 3200
2 0;122 NaN NaN NaN NaN]

100

8.22E+00

122

3.58E+00

[0 55 6.2 3200 900;100 75 6.2 3200
3 0;124 NaN NaN NaN NaN]

100

8.22E+00

124

3.21E+00

[0 55 6.2 3200 900;100 75 6.2 3200
4 0;126 NaN NaN NaN NaN]

100

8.22E+00

126

2.86E+00

[0 55 6.2 3200 900;100 75 6.2 3200
5 0;128 NaN NaN NaN NaN]

100

8.22E+00

128

2.55E+00

[0 55 6.2 3200 900;100 75 6.2 3200
6 0;130 NaN NaN NaN NaN]

100

8.22E+00

130

2.25E+00

[0 55 6.2 3200 900;100 75 6.2 3200
7 0;132 NaN NaN NaN NaN]

100

8.22E+00

132

1.98E+00

[0 55 6.2 3200 900;100 75 6.2 3200
8 0;134 NaN NaN NaN NaN]

100

8.22E+00

134

1.74E+00

[0 55 6.2 3200 900;100 75 6.2 3200
9 0;136 NaN NaN NaN NaN]

100

8.22E+00

136

1.51E+00

[0 55 6.2 3200 900;100 75 6.2 3200
10 0;138 NaN NaN NaN NaN]

100

8.22E+00

138

1.30E+00

[0 55 6.2 3200 900;100 75 6.2 3200
11 0;140 NaN NaN NaN NaN]

100

8.22E+00

140

1.11E+00

[0 55 6.2 3200 900;100 75 6.2 3200
12 0;142 NaN NaN NaN NaN]

100

8.22E+00

142

9.27E-01

[0 55 6.2 3200 900;100 75 6.2 3200
13 0;144 NaN NaN NaN NaN]

100

8.22E+00

144

7.60E-01

[0 55 6.2 3200 900;100 75 6.2 3200
14 0;146 NaN NaN NaN NaN]

100

8.22E+00

146

6.04E-01

[0 55 6.2 3200 900;100 75 6.2 3200
15 0;148 NaN NaN NaN NaN]

100

8.22E+00

148

4.58E-01
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Some of the simulations run at 55˚C were found to fall within the constraints required for
the process, simulations 3-6. Based on these results, the sweet spot for the process.

The next step was determining if altering the humidity values would affect the LOD values.
The black-box modal does not account for any control for the condenser. Additionally, the
humidity of the ambient air differs from day to day. As told by the project author, the
condenser lets any air humidity over the value of 7.6(kg H2O/kg air) through the process
automatically. To prove that this assumption was true for lower values of humidity as well,
simulations were run at lower humidity values.
Sim Humidity
#
Value

Input Matrix

Max LOD
Time [min]

Max LOD
[%]

End Time End LOD
[min]
[%]

1

[0 55 1 3200 900;100 75 1 3200
1 0;120 NaN NaN NaN NaN]

100

6.75E+00

120

2.62E+00

2

[0 55 1 3200 900;100 75 1 3200
1 0;122 NaN NaN NaN NaN]

100

6.75E+00

122

2.32E+00

3

[0 55 1 3200 900;100 75 1 3200
1 0;124 NaN NaN NaN NaN]

100

6.75E+00

124

2.04E+00

4

[0 55 2 3200 900;100 75 2 3200
2 0;120 NaN NaN NaN NaN]

100

7.03E+00

120

2.85E+00

5

[0 55 2 3200 900;100 75 2 3200
2 0;122 NaN NaN NaN NaN]

100

7.03E+00

122

2.53E+00

6

[0 55 2 3200 900;100 75 2 3200
2 0;124 NaN NaN NaN NaN]

100

7.03E+00

124

2.23E+00

7

[0 55 3 3200 900;100 75 3 3200
3 0;120 NaN NaN NaN NaN]

100

7.31E+00

120

3.09E+00

8

[0 55 3 3200 900;100 75 3 3200
3 0;122 NaN NaN NaN NaN]

100

7.31E+00

122

2.75E+00

9

[0 55 3 3200 900;100 75 3 3200
3 0;124 NaN NaN NaN NaN]

100

7.31E+00

124

2.44E+00

10

[0 55 3 3200 900;100 75 3 3200
3 0;126 NaN NaN NaN NaN]

100

7.31E+00

126

2.15E+00

11

[0 55 4 3200 900;100 75 4 3200
4 0;120 NaN NaN NaN NaN]

100

7.60E+00

120

3.35E+00

12

[0 55 4 3200 900;100 75 4 3200
4 0;122 NaN NaN NaN NaN]

100

7.60E+00

122

2.99E+00
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13

[0 55 4 3200 900;100 75 4 3200
4 0;124 NaN NaN NaN NaN]

100

7.60E+00

124

2.66E+00

14

[0 55 4 3200 900;100 75 4 3200
4 0;126 NaN NaN NaN NaN]

100

7.60E+00

126

2.35E+00

15

[0 55 4 3200 900;100 75 4 3200
4 0;128 NaN NaN NaN NaN]

100

7.60E+00

128

2.07E+00

16

[0 55 5 3200 900;100 75 5 3200
5 0;120 NaN NaN NaN NaN]

100

7.88E+00

120

3.63E+00

17

[0 55 5 3200 900;100 75 5 3200
5 0;122 NaN NaN NaN NaN]

100

7.88E+00

122

3.25E+00

18

[0 55 5 3200 900;100 75 5 3200
5 0;124 NaN NaN NaN NaN]

100

7.88E+00

124

2.90E+00

19

[0 55 5 3200 900;100 75 5 3200
5 0;126 NaN NaN NaN NaN]

100

7.88E+00

126

2.58E+00

20

[0 55 5 3200 900;100 75 5 3200
5 0;128 NaN NaN NaN NaN]

100

7.88E+00

128

2.28E+00

21

[0 55 5 3200 900;100 75 5 3200
5 0;130 NaN NaN NaN NaN]

100

7.88E+00

130

2.01E+00

22

[0 55 7.6 3200 900;100 75 7.6
7.6 3200 0;126 NaN NaN NaN NaN]

100

8.61E+00

126

3.23E+00

23

[0 55 7.6 3200 900;100 75 7.6
7.6 3200 0;128 NaN NaN NaN NaN]

100

8.61E+00

128

2.89E+00

24

[0 55 7.6 3200 900;100 75 7.6
7.6 3200 0;130 NaN NaN NaN NaN]

100

8.61E+00

130

2.57E+00

25

[0 55 7.6 3200 900;100 75 7.6
7.6 3200 0;132 NaN NaN NaN NaN]

100

8.61E+00

132

2.28E+00

26

[0 55 7.6 3200 900;100 75 7.6
7.6 3200 0;134 NaN NaN NaN NaN]

100

8.61E+00

134

2.01E+00

As shown above, these were the simulations run at lower humidity values. It was proven
that at lower humidity values, keeping all other inputs constant there did exists simulations
that provided wanted LOD values.
Based on all the data collected from the simulations, it was determined that the process
could operate at any humidity value as long as the other inputs are optimized.
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Section 26.5 Lyophilization Simulation Results

Drying Time vs. Initial Chamber Temperature for 8R
Vials
45
40

Drying Time (hr)

35
30
25
20
15
10
5
0
-30

-25

-20

-15

-10

-5

0

Initial Chamber Temperature (C)
10 Pa

20 Pa

30 Pa

40 Pa

Figure 26.5.1. As temperature increases, drying time decreases. As pressure increases, drying time decreases.
Lower drying times are preferable.
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Peak Product Temperature vs. Initial Chamber
Temperature for 8R Vials
-16
-25

-20

-15

-10

Peak Product Temperature (C)

-30

-5

-18

0

-20
-22
-24
-26
-28
-30
-32

Initial Temperature (C)
10 Pa

20 Pa

30 Pa

-34

40 Pa

Figure 26.5.2. As temperature increases, peak product temperature increases. As pressure increases, peak
product temperature increases. Peak product temperatures above -21.0 ˚C do not satisfy product quality
requirements.
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Maximum Sublimation Rate vs. Initial Chamber
Temperature for 8R Vials
Maximum Sublimation Rate (g/s)

1.60E-04
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40 Pa

Figure 26.5.3. The maximum sublimation rate is a function of the heat transfer properties of the vial. As
temperature increases, maximum sublimation rate increases. At temperatures below -16˚C, maximum
sublimation rate increases as pressure decreases. At temperatures above -16˚C, maximum sublimation rate
increases as pressure increases.
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Number of 8R Vials vs. Initial Chamber Temperature at
10 Pa
70000
60000

Number of Vials

50000
40000
30000
20000
10000
0
-30

-25

-20

-15

-10

-5

0

Initial Chamber Temperature (C)

Figure 26.5.4. The lyophilization chamber can handle 50,000 vials at temperatures up to -26˚C, 40,000 vials at
temperatures up to -17˚C, 30,000 vials at temperatures up to -6˚C, and only 20,000 vials at higher
temperatures. This low batch size makes operation at 10 Pa economically unfavorable.
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Number of 8R Vials vs. Initial Chamber Temperature at
20 Pa
70000
60000

Number of Vials

50000
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-10
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0
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Figure 26.5.5. The lyophilization chamber can handle 60,000 vials at temperatures up to -15˚C, 50,000 vials at
temperatures up to -10˚C, and 40,000 vials at higher temperatures.
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Number of 8R Vials vs. Initial Chamber Temperature at
30 Pa
70000
60000
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-10

-5

0
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Figure 26.5.6. The lyophilization chamber can handle 60,000 vials at temperatures up to -9˚C and 50,000 vials
at higher temperatures.
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Number of 8R Vials vs. Initial Chamber Temperature at
40 Pa
70000
60000
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Figure 26.5.7. The lyophilization chamber can handle 60,000 vials at every simulated temperature.
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Drying Time vs. Initial Chamber Temperature for 20 mL
Vials
40

Drying Time (hr)
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Figure 26.5.8. As temperature increases, drying time decreases. As pressure increases, drying time decreases.
Lower drying times are preferable.
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Peak Product Temperature vs. Initial Chamber
Temprature
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Figure 26.5.9. As temperature increases, peak product temperature increases. As pressure increases, peak
product temperature increases. All simulations satisfied peak product temperature constraints.
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Maximum Sublimation Rate vs. Initial Chamber
Temperature for 20 mL Vials
Maximum Sublimation Rate (g/s)
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Figure 26.5.10. As temperature increases, maximum sublimation rate increases. As pressure increases,
maximum sublimation rate decreases.
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Number of 20 mL Vials vs. Initial Chamber Temperature
(C) at 10 Pa
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Figure 26.5.11. The lyophilization chamber can handle 20,000 vials at temperatures up to -15˚C and only
10,000 vials at higher temperatures. This low batch size makes operation at 10 Pa economically unfavorable.
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Number of 20 mL Vials vs. Initial Chamber Temperature
(C) at 20 Pa
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Figure 26.5.12. The lyophilization chamber can handle 50,000 vials at temperatures up to -25˚C, 40,000 vials
up to -20˚C, 30,000 vials up to -9˚C and only 20,000 vials at higher temperatures.
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Number of 20 mL Vials vs. Initial Chamber Temperature
(C) at 30 Pa
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Figure 26.5.13. The lyophilization chamber can handle 60,000 vials at temperatures up to -20˚C, 50,000 vials
up to -15˚C, 40,000 vials up to -8˚C and only 30,000 vials at higher temperatures.
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Number of 20 mL Vials vs. Initial Chamber Temperature
(C) at 40 Pa
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Figure 26.5.14. The lyophilization chamber can handle 60,000 vials at temperatures up to -14˚C, 50,000 vials
up to -8˚C and only 40,000 vials at higher temperatures.
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Section 26.6 Economic Cost Summaries
Fluid Bed Granulation Base Case – Power Usage
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186

Figures 26.6.1-5 – Detailed economic summaries of how power functions were calculated for the base case. In
descending order, figures correspond to condenser, heat exchanger, fan, heater, and pump power usage

Fluid Bed Granulation Recommended Case
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Figures 26.6.6-10 – Detailed economic summaries of how power functions were calculated for the
recommended case. In descending order, figures correspond to condenser, heat exchanger, fan, heater, and
pump power usage
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Lyophilization Base Case – Vacuum Pump Power Usage
*Power usage for the other pieces of equipment were calculated externally using Matlab
and manually input into the model

Figures 26.6.11 – Detailed economic summary of how power functions were calculated for the base case (26
Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure. Other power
functions were calculated manually.

Lyophilization Recommended Case (8R) – Vacuum Pump Power Usage

Figures 26.6.12 – Detailed economic summary of how power functions were calculated for the recommended
case (30 Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure.
Other power functions were calculated manually.
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Lyophilization Base Case (20ml) – Vacuum Pump Power Usage

Figures 26.6.13 – Detailed economic summary of how power functions were calculated for the recommended
case (30 Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure.
Other power functions were calculated manually.

Section 26.7 Financial Summary of NPV Analysis
Fluid Bed Granulation
Table 26.7.1 – Base case cashflow summary for NPV analysis over 15 year life. Sales and non-operational costs
were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was
applied.
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Table 26.7.2 – Recommended case cashflow summary for NPV analysis over 15 year life. Recommended case
corresponds to 28.3% annual operational cost savings. Sales and non-operational costs were assumed constant
for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was applied.

Table 26.7.3 – 10% savings case cash flow summary for NPV analysis over 15 year life. Sales and non-operational
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23%
was applied.
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Table 26.7.4 – 35% savings case cash flow summary for NPV analysis over 15 year life. Sales and non-operational
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23%
was applied.

Lyophilization
Table 26.7.5 – Base case cashflow summary for NPV analysis over 15 year life. Sales and non-operational costs
were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was
applied.
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Table 26.7.6 – Recommended case cashflow summary for NPV analysis over 15 year life. Recommended case
corresponds to 16.4% annual operational cost savings. Sales and non-operational costs were assumed constant
for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was applied.

Table 26.7.7 – 7.5% savings case cashflow summary for NPV analysis over 15 year life. Sales and non-operational
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23%
was applied.
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Table 26.7.7 – 30% savings case cashflow summary for NPV analysis over 15 year life. Sales and non-operational
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23%
was applied.
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